https://www.pharmaceutical-business-review.com/news/kamadas-glassia-gets-fda-orphan-drug-status-for-gvhd-treatment-301014-4422909/ 2014-10-30T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-accelerated-approval-for-pfizer-meningococcal-b-vaccine-trumenba-301014-4422985/ 2014-10-30T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-expands-manufacturing-agreement-with-lonza-311014-4423294/ 2014-10-31T00:28:00+00:00 https://www.pharmaceutical-business-review.com/news/retrosense-gets-fda-orphan-drug-status-for-rst-001-to-treat-retinitis-pigmentosa-311014-4423423/ 2014-10-31T00:28:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-introduces-incruse-ellipta-in-uk-for-copd-patients-311014-4423369/ 2014-10-31T00:29:00+00:00 https://www.pharmaceutical-business-review.com/news/auspex-begins-phase-iii-aim-td-trial-of-sd-809-in-patients-with-tardive-dyskinesia-311014-4423494/ 2014-10-31T01:51:00+00:00 https://www.pharmaceutical-business-review.com/news/onxeo-reports-positive-preliminary-results-from-validive-phase-ii-trial-for-oral-mucositis-311014-4423631/ 2014-10-31T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-xigduo-xr-combination-diabetes-drug-gets-fda-approval-311014-4423566/ 2014-10-31T02:43:00+00:00 https://www.pharmaceutical-business-review.com/news/cirrus-pharmaceuticals-to-invest-in-cgmp-manufacturing-suite-in-us-311014-4423855/ 2014-10-31T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/levolta-receives-us-patent-for-new-investigational-therapy-for-controlling-osteoarthritis-311014-4423867/ 2014-10-31T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/tribute-pharmaceuticals-secures-uracyst-patent-in-europe-311014-4423874/ 2014-10-31T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/aslan-selects-medidata-as-enterprise-wide-technology-platform-to-improve-clinical-development-311014-4423847/ 2014-10-31T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/affinivax-launches-new-conjugate-vaccine-for-ggobal-impact-on-infectious-diseases-311014-4423843/ 2014-10-31T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/medivation-astellas-to-initiate-phase-iii-trial-of-prostate-cancer-drug-enzalutamide-311014-4424436/ 2014-10-31T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-invests-126m-on-new-diabetes-labs-at-mlv-rd-campus-031114-4424949/ 2014-11-03T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/lct-completes-patient-enrollment-in-phase-iiia-trial-for-parkinsons-disease-031114-4425235/ 2014-11-03T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-signs-deal-to-transfer-ofatumumab-collaboration-from-gsk-to-novartis-031114-4425193/ 2014-11-03T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/zogenix-purdue-exchange-waivers-of-regulatory-exclusivity-for-extended-release-hydrocodone-products-031114-4425148/ 2014-11-03T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-zymogenetics-rd-facility-earns-leed-silver-certification-from-us-green-building-council-031114-4425176/ 2014-11-03T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/profectus-gets-95m-department-of-defense-funding-to-manufacture-trivalent-vesiculovax-vectored-vaccine-031114-4425160/ 2014-11-03T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/optinose-reports-pivotal-phase-iii-results-for-migraine-treatment-developed-using-bi-directional-breath-powered-technology-031114-4425143/ 2014-11-03T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/us-federal-trade-commission-clears-actavis-proposed-acquisition-of-durata-031114-4425170/ 2014-11-03T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-committee-backs-daiichi-sankyos-savaysa-for-stroke-risk-and-see-in-nvaf-patients-031114-4425924/ 2014-11-03T08:45:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-and-sobis-elocta-maa-validated-by-ema-031114-4425909/ 2014-11-03T08:46:00+00:00 https://www.pharmaceutical-business-review.com/news/xcovery-reports-positive-results-from-phase-i-trial-of-x-396-in-alk-positive-nsclc-031114-4425996/ 2014-11-03T08:47:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-completes-takeover-of-chinese-otc-drug-maker-dihon-for-470m-041114-4426337/ 2014-11-04T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-gains-rights-to-almiralls-respiratory-franchise-041114-4426532/ 2014-11-04T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-signs-exclusive-option-deal-to-buy-galecto-and-new-galectin-3-inhibitor-041114-4426416/ 2014-11-04T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/cvs-health-announces-10m-commitment-to-fund-innovative-cancer-research-041114-4427320/ 2014-11-04T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvilex-to-commercialize-breakthrough-diabetes-research-041114-4427332/ 2014-11-04T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/intra-cellular-takeda-terminate-collaboration-to-develop-pde1-inhibitors-for-cns-disorders-041114-4427341/ 2014-11-04T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/otsuka-lundbeck-report-results-from-qualify-study-of-once-monthly-aripiprazole-041114-4427361/ 2014-11-04T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-pasteur-gets-fda-approval-for-fluzone-high-dose-influenza-vaccine-for-adults-65-and-older-041114-4427380/ 2014-11-04T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/ex-scientia-sunovion-partner-for-new-medicines-to-treat-psychiatric-disorders-041114-4427439/ 2014-11-04T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-boehringers-nda-for-asthma-treatment-respimat-041114-4427482/ 2014-11-04T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-isavuconazole-gets-fda-orphan-drug-status-to-treat-invasive-candidiasis-041114-4427453/ 2014-11-04T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/scynexis-grants-waterstone-worldwide-rights-of-scy-635-to-treat-viral-diseases-041114-4427496/ 2014-11-04T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-pharmacyclics-and-janssen-collaborate-on-immuno-oncology-combination-trials-051114-4427797/ 2014-11-04T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/aberdeen-universitys-research-shows-frequency-of-addiction-to-otc-medicines-051114-4428189/ 2014-11-05T02:07:00+00:00 https://www.pharmaceutical-business-review.com/news/xoma-begins-phase-iii-trial-of-gevokizumab-to-treat-active-ulcers-in-pg-patients-051114-4428238/ 2014-11-05T02:27:00+00:00 https://www.pharmaceutical-business-review.com/news/abide-therapeutics-partners-with-oxford-university-on-new-drug-targets-051114-4428284/ 2014-11-05T02:57:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-ind-number-for-regens-dcellvax-therapeutic-application-to-treat-breast-cancer-051114-4428437/ 2014-11-05T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/d-pharm-reports-first-results-from-its-phase-2-clinical-study-of-thr-18-051114-4428415/ 2014-11-05T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/dana-farber-cancer-institute-astellas-to-research-and-develop-small-molecule-inhibitors-of-oncogenic-k-ras-051114-4428425/ 2014-11-05T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/imprimis-signs-distribution-deal-to-bring-go-dropless-proprietary-formulations-to-ophthalmologists-in-puerto-rico-051114-4428445/ 2014-11-05T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-panel-grants-positive-opinion-on-odd-of-inventivas-iva337-051114-4428342/ 2014-11-05T07:31:00+00:00 https://www.pharmaceutical-business-review.com/news/ruthigen-starts-patient-enrolment-in-phase-iii-trial-of-rut58-60-051114-4429008/ 2014-11-05T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-enrolls-first-patient-in-phase-ii-vatelizumab-trial-in-rrms-patients-051114-4429051/ 2014-11-05T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-gets-fda-approval-to-market-fenofibrate-capsules-usp-43mg-and-130mg-061114-4431585/ 2014-11-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/new-england-controls-partners-with-continuus-pharmaceuticals-to-implement-breakthrough-continuous-manufacturing-technology-for-pharmaceuticals-4458203/ 2014-11-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-opens-new-ebola-treatment-centre-in-sierra-leone-061114-4429452/ 2014-11-05T23:51:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-gets-fda-approval-for-gastric-cancer-combination-drug-061114-4429834/ 2014-11-06T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-files-ind-application-to-fda-for-prostate-cancer-drug-adxs31-142-061114-4429833/ 2014-11-06T02:45:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-seeks-approval-for-asthma-drug-mepolizumab-in-us-and-europe-061114-4429856/ 2014-11-06T02:51:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-reports-final-results-of-phase-iii-trial-for-new-celiac-treatment-061114-4429943/ 2014-11-06T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/the-medicines-company-enrolls-first-patient-in-phase-iii-studies-of-carbavance-to-treat-serious-bacterial-infections-061114-4429948/ 2014-11-06T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/invetech-argos-ink-deal-to-support-global-production-of-fully-personalized-immunotherapies-061114-4429960/ 2014-11-06T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/mmrf-leads-new-initiative-to-accelerate-development-of-targeted-therapies-for-multiple-myeloma-061114-4429968/ 2014-11-06T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/celsion-secures-vhp-approval-to-start-phase-iii-optima-liver-cancer-trial-061114-4429935/ 2014-11-06T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/mpi-alion-to-develop-drug-response-predictors-for-ion-channel-inhibitors-in-oncology-061114-4429959/ 2014-11-06T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/merrimack-gets-fda-orphan-drug-designation-for-pancreatic-cancer-drug-candidate-mm-141-061114-4429905/ 2014-11-06T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-divests-myalept-for-325m-to-aegerion-071114-4430883/ 2014-11-06T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/auspexs-sd-809-gets-fda-orphan-drug-status-to-treat-huntingtons-disease-071114-4431283/ 2014-11-07T03:05:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-agrees-to-buy-otc-firm-omega-pharma-for-36bn-071114-4431331/ 2014-11-07T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/pdl-biopharma-acquires-portion-of-michigan-universitys-royalty-interest-in-genzymes-cerdelga-for-656m-071114-4431609/ 2014-11-07T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/viacyte-gets-us-patent-claiming-alternative-methods-to-manufacture-pancreatic-progenitor-cells-in-vitro-071114-4431619/ 2014-11-07T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/provectus-submits-pv-10-phase-iii-melanoma-protocol-to-fda-071114-4431600/ 2014-11-07T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/heron-discloses-new-iv-formulation-of-nk-1-receptor-antagonist-to-prevent-cinv-071114-4431627/ 2014-11-07T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/gvk-bio-agrees-to-buy-vanta-bioscience-071114-4432002/ 2014-11-07T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-breakthrough-therapy-status-for-sparks-night-blindness-drug-spk-rpe65-071114-4431377/ 2014-11-07T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/merrimack-enrolls-first-patient-in-phase-i-brain-cancer-trial-of-mm-398-071114-4431914/ 2014-11-07T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-files-nda-for-taf-based-single-tablet-regimen-to-treat-hiv-071114-4431965/ 2014-11-07T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/micreos-launches-first-bacteria-killing-enzyme-for-human-use-asgainst-mrsa-071114-4431595/ 2014-11-07T11:28:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-reports-data-from-afatinib-phase-iii-lux-lung-3-trial-in-asian-nsclc-patients-101114-4432441/ 2014-11-10T00:38:00+00:00 https://www.pharmaceutical-business-review.com/news/jj-acquires-orsl-energy-drink-brand-from-indias-jagdale-industries-101114-4432931/ 2014-11-10T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/idera-parent-project-muscular-dystrophy-partner-to-advance-new-treatment-approach-for-duchenne-muscular-dystrophy-101114-4432860/ 2014-11-10T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/lycera-announces-research-showing-new-oral-immunotherapy-possesses-potent-single-agent-anti-cancer-activity-101114-4432877/ 2014-11-10T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/advent-avista-capital-partners-to-acquire-kremers-urban-pharmaceuticals-from-ucb-101114-4432888/ 2014-11-10T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/avanir-reports-preliminary-feedback-from-fda-on-avp-825-for-the-acute-treatment-of-migraine-101114-4432869/ 2014-11-10T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/cardiome-reports-positive-results-from-phase-iii-brinavess-trial-in-atrial-fibrillation-patients-101114-4433441/ 2014-11-10T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvilex-seeks-orphan-drug-status-for-pancreatic-cancer-treatment-in-australia-101114-4433614/ 2014-11-10T07:58:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-gets-fda-fast-track-status-for-lymphoma-drug-mor208-101114-4433556/ 2014-11-10T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-completes-acquisition-of-alios-biopharma-for-175bn-101114-4432775/ 2014-11-10T08:06:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-reports-data-from-phase-iii-unity-trials-of-dcv-trio-regimen-101114-4433626/ 2014-11-10T08:22:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-amgens-bla-for-ldl-cholesterol-lowering-drug-evolocumab-111114-4433806/ 2014-11-10T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/pharco-to-develop-presidios-ns5a-inhibitor-ppi-668-for-hcv-in-egypt-111114-4434432/ 2014-11-11T03:11:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-makes-trulicity-available-in-us-pharmacies-for-adults-with-type-2-diabetes-111114-4434394/ 2014-11-11T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/octapharmas-nuwiq-gets-health-canada-approval-to-treat-hemophilia-a-111114-4434534/ 2014-11-11T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/engeneic-adri-begin-mesomir-1-phase-i-trial-in-patients-with-late-stage-mesothelioma-111114-4434581/ 2014-11-11T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/plandai-collaboration-offers-opportunity-to-produce-a-non-psychoactive-cannabis-product-for-medical-research-111114-4434606/ 2014-11-11T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/swander-pace-capital-forms-clarion-brands-acquires-six-otc-brands-from-dse-healthcare-111114-4434587/ 2014-11-11T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/encycle-therapeutics-developing-lead-molecule-to-tackle-inflammatory-bowel-disease-111114-4434608/ 2014-11-11T06:02:00+00:00 https://www.pharmaceutical-business-review.com/news/cartagenia-collabrx-partner-to-provide-pathology-laboratories-and-cancer-centers-access-to-personalized-information-on-therapeutic-options-111114-4434597/ 2014-11-11T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/konared-partners-with-dixon-marketing-111114-4434616/ 2014-11-11T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/karyopharm-begins-selinexor-phase-ii-trial-in-patients-with-richters-transformation-111114-4435126/ 2014-11-11T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/scinopharm-nkf-partner-to-jointly-enter-chinese-market-for-new-drugs-111114-4435151/ 2014-11-11T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-partners-with-ge-healthcare-to-develop-new-drugs-for-liver-diseases-121114-4435633/ 2014-11-12T00:09:00+00:00 https://www.pharmaceutical-business-review.com/news/stellar-araclon-sign-klh-supply-deal-for-clinical-trials-in-alzheimers-active-immunotherapies-121114-4435766/ 2014-11-12T01:51:00+00:00 https://www.pharmaceutical-business-review.com/news/bioatla-bioduro-partner-for-two-new-drug-candidates-targeting-major-indications-in-china-121114-4435703/ 2014-11-12T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/enzymotec-begins-vayarin-clinical-trial-in-adults-with-adhd-121114-4436034/ 2014-11-12T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/vaxinnate-completes-patient-enrollment-in-vax2012q-phase-i-influenza-vaccine-trial-121114-4436066/ 2014-11-12T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/adeptnature-launches-all-natural-skin-product-phytoceramides-121114-4436243/ 2014-11-12T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-expands-hepatic-infectious-disease-pipeline-121114-4436277/ 2014-11-12T04:23:00+00:00 https://www.pharmaceutical-business-review.com/news/enanta-reports-results-from-turquoise-i-study-in-chronic-hepatitis-c-patients-with-hiv-1-co-infection-121114-4436251/ 2014-11-12T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/prometics-pbi-4050-gets-approval-to-start-clinical-trials-in-patients-with-diabetic-kidney-disease-121114-4436266/ 2014-11-12T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/arqule-nih-collaborate-for-clinical-development-of-arq-092-in-proteus-syndrome-121114-4436261/ 2014-11-12T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-for-thresholds-sarcoma-drug-th-302-121114-4436100/ 2014-11-12T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/aveo-ophthotechr-enter-research-and-option-deal-for-tivozanib-to-treat-ocular-diseases-121114-4436579/ 2014-11-12T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-submits-ind-for-phase-iii-trial-of-adxs-hpv-and-medi4736-in-hpv-associated-cancers-131114-4437305/ 2014-11-13T00:31:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-seeks-european-approval-for-additional-indication-of-eltrombopag-to-treat-saa-131114-4437442/ 2014-11-13T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-announces-favorable-markman-ruling-in-rayos-delayed-release-tablets-patent-infringement-litigation-131114-4438133/ 2014-11-13T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/amag-pharmaceuticals-acquires-lumara-healths-maternal-health-business-131114-4438112/ 2014-11-13T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/clovis-oncology-enrolls-first-patient-in-tiger-1-study-131114-4438100/ 2014-11-13T06:16:00+00:00 https://www.pharmaceutical-business-review.com/news/capstone-nutrition-unveiled-as-new-leader-in-nutraceutical-product-development-and-manufacturing-131114-4438123/ 2014-11-13T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/neurens-nnz-2566-successful-in-showing-clinical-benefit-in-rett-syndrome-phase-ii-trial-131114-4438149/ 2014-11-13T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/sarepta-starts-dosing-dmd-patients-in-eteplirsen-trial-131114-4438303/ 2014-11-13T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/casi-gets-china-fda-nod-to-initiate-phase-ii-trial-of-enmd-2076-to-treat-soft-tissue-sarcoma-131114-4438406/ 2014-11-13T07:48:00+00:00 https://www.pharmaceutical-business-review.com/news/par-pharmaceutical-gets-fda-approval-of-vasostrict-131114-4438417/ 2014-11-13T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/onl-therapeutics-gets-phase-ii-sbir-grant-from-nei-to-develop-new-retinal-disease-treatment-131114-4438441/ 2014-11-13T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/medgenics-chop-enter-rare-and-orphan-disease-research-collaboration-131114-4438453/ 2014-11-13T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/us-patent-innovations-opens-research-facility-to-advance-uses-of-plasma-technology-and-techniques-in-medicine-141114-4441072/ 2014-11-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-isis-to-jointly-develop-targeted-oligonucleotide-delivery-methods-141114-4439983/ 2014-11-13T23:39:00+00:00 https://www.pharmaceutical-business-review.com/news/galmed-doses-first-patient-in-its-phase-iia-trial-of-aramchol-to-treat-cholesterol-gallstones-141114-4439981/ 2014-11-13T23:40:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-begins-phase-ii-trial-of-riociguat-to-treat-patients-with-dcssc-141114-4438616/ 2014-11-13T23:41:00+00:00 https://www.pharmaceutical-business-review.com/news/janssens-sndas-for-invega-sustenna-gets-fda-approval-to-treat-schizoaffective-disorders-141114-4439098/ 2014-11-14T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-expand-sayana-press-contraceptive-access-to-poor-countries-141114-4439463/ 2014-11-14T06:11:00+00:00 https://www.pharmaceutical-business-review.com/news/dynasils-rmd-subsidiary-gets-35m-in-technology-development-grants-from-nih-141114-4439440/ 2014-11-14T06:13:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-begins-development-programme-for-brilinta-reversal-agent-141114-4439457/ 2014-11-14T06:16:00+00:00 https://www.pharmaceutical-business-review.com/news/integral-molecular-gets-35m-nih-contract-to-study-ebola-and-hepatitis-c-virus-antibody-response-141114-4439428/ 2014-11-14T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/highland-therapeutics-gets-notice-of-allowance-from-uspto-for-patent-on-lead-product-141114-4439449/ 2014-11-14T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/aurobindo-pharma-usa-emerges-as-highest-bidder-to-acquire-otc-firm-natrol-141114-4439853/ 2014-11-14T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-actavis-snda-for-saphris-to-treat-bipolar-i-disorder-in-pediatric-patients-141114-4439896/ 2014-11-14T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-seeks-proposals-for-non-communicable-diseases-research-in-africa-141114-4439978/ 2014-11-14T08:17:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-to-build-new-large-scale-biologics-manufacturing-plant-in-ireland-171114-4440972/ 2014-11-17T03:21:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-genzymes-lemtrada-to-treat-multiple-sclerosis-171114-4440914/ 2014-11-17T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/recipharm-acquires-lusomedicamenta-for-sek-1-billion-171114-4441029/ 2014-11-17T03:28:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-reports-positive-phase-ii-trial-results-of-melanoma-drug-pembrolizumab-171114-4441478/ 2014-11-17T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/ul-information-insights-launches-online-marketplace-for-dietary-supplement-industry-171114-4441062/ 2014-11-17T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/beigene-completes-75m-financing-171114-4441049/ 2014-11-17T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-reports-positive-initial-phase-ii-data-with-revusiran-to-treat-ttr-cardiac-amyloidosis-171114-4441087/ 2014-11-17T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/cortice-biosciences-reports-initial-results-from-a-phase-iii-trial-of-tpi-287-to-treat-recurrent-glioblastoma-171114-4441102/ 2014-11-17T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-gets-fda-approval-for-avastin-to-treat-ovarian-cancer-171114-4441589/ 2014-11-17T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/genticel-closes-patient-enrolment-in-phase-ii-procervix-trial-171114-4441684/ 2014-11-17T08:05:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-reports-positive-phase-iii-trial-results-of-melanoma-drug-opdivo-171114-4441649/ 2014-11-17T08:06:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-wellpoint-and-healthcore-start-new-multi-year-research-collaboration-171114-4441699/ 2014-11-17T08:08:00+00:00 https://www.pharmaceutical-business-review.com/news/inovio-and-roche-terminate-joint-development-agreement-for-ino-5150-181114-4443256/ 2014-11-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-merck-to-jointly-develop-and-commercialize-new-cancer-treatments-181114-4441990/ 2014-11-17T23:41:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-agrees-to-buy-botox-maker-allergan-for-66bn-181114-4442113/ 2014-11-18T00:23:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-trade-name-auryxia-for-keryxs-ferric-citrate-181114-4442233/ 2014-11-18T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-gets-health-canada-approval-for-generic-celebrex-181114-4442437/ 2014-11-18T02:58:00+00:00 https://www.pharmaceutical-business-review.com/news/oxigene-gets-european-patent-for-oxi4503-in-aml-and-other-myeloid-malignancies-181114-4442543/ 2014-11-18T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/birmingham-university-gets-grant-to-support-human-research-on-chromadexs-niagen-nicotinamide-riboside-181114-4442577/ 2014-11-18T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/retrosense-therapeutics-signs-license-deal-with-massachusetts-general-hospital-181114-4442554/ 2014-11-18T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/kite-pharma-gets-positive-opinion-for-orphan-drug-designation-in-europe-for-cancer-immunotherapy-181114-4442569/ 2014-11-18T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/dicerna-inks-license-agreement-with-tekmira-to-advance-ph1-development-program-181114-4442565/ 2014-11-18T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/novavax-starts-patient-enrolment-in-phase-ii-trial-of-quadrivalent-seasonal-influenza-vlp-181114-4443221/ 2014-11-18T08:03:00+00:00 https://www.pharmaceutical-business-review.com/news/cardiome-inks-commercialization-deal-with-aspen-for-brinavess-in-south-africa-181114-4443235/ 2014-11-18T08:15:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-gets-approval-in-japan-for-eylea-to-treat-diabetic-macular-edema-191114-4443547/ 2014-11-18T23:55:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-launches-meningococcal-group-b-vaccine-trumenba-in-us-191114-4443597/ 2014-11-19T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/gileads-hepatitis-c-drug-harvoni-gets-marketing-authorization-in-europe-191114-4443636/ 2014-11-19T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/3sbio-enters-into-license-deal-with-pharmabcine-for-tanibirumab-191114-4443758/ 2014-11-19T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/aphios-gets-us-patent-for-nanotechnology-co-encapsulation-of-combination-drugs-and-drug-products-191114-4444215/ 2014-11-19T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-allows-fibrocells-ind-application-for-new-wounded-warrior-amputees-to-prevent-stump-skin-diseases-191114-4444185/ 2014-11-19T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/edge-therapeutics-enters-research-collaboration-with-leading-academic-medical-center-191114-4444197/ 2014-11-19T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/intellia-announces-15m-in-funding-to-develop-therapeutic-products-using-crispr-cas9-gene-editing-technology-191114-4444206/ 2014-11-19T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-introduces-liquid-formulation-of-treanda-injection-in-us-191114-4444533/ 2014-11-19T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/cytrx-gets-fda-notice-on-partial-clinical-hold-of-aldoxorubicin-clinical-trials-191114-4444689/ 2014-11-19T07:39:00+00:00 https://www.pharmaceutical-business-review.com/news/galena-biopharma-closes-enrollment-in-phase-ii-trial-of-gale-401-191114-4444745/ 2014-11-19T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/otologic-starts-phase-i-hnpn-1010-trial-to-treat-hearing-disorders-201114-4446108/ 2014-11-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sunshine-selects-lonza-to-manufacture-anti-cancer-drug-adva-27a-201114-4446114/ 2014-11-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-submits-nda-for-three-month-paliperidone-palmitate-to-treat-schizophrenia-in-us-201114-4445029/ 2014-11-19T23:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-for-merrimacks-pancreatic-cancer-drug-mm-398-201114-4445129/ 2014-11-20T01:16:00+00:00 https://www.pharmaceutical-business-review.com/news/axxess-pharma-gets-approval-to-sell-high-potency-omega-3-fish-oil-supplement-in-canada-201114-4445240/ 2014-11-20T01:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-bergenbios-bgb324-to-treat-acute-myeloid-leukaemia-201114-4445390/ 2014-11-20T02:25:00+00:00 https://www.pharmaceutical-business-review.com/news/cdisc-and-transcelerate-announce-availability-of-new-standards-for-diabetes-and-cardiovascular-disease-201114-4445528/ 2014-11-20T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/cynapsus-reports-positive-top-line-results-from-cth-105-phase-ii-trial-of-apl-130277-to-treat-parkinsons-disease-201114-4445538/ 2014-11-20T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-opens-next-generation-biomanufacturing-facility-in-singapore-201114-4445522/ 2014-11-20T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/medidata-transcelerate-report-findings-of-joint-research-initiative-on-clinical-trial-site-monitoring-methods-201114-4445533/ 2014-11-20T06:36:00+00:00 https://www.pharmaceutical-business-review.com/news/aspira-to-distribute-nagases-unnatural-amino-acids-for-next-generation-drug-candidate-development-201114-4445546/ 2014-11-20T06:38:00+00:00 https://www.pharmaceutical-business-review.com/news/oncore-blumberg-enter-exclusive-hbv-research-collaboration-201114-4445421/ 2014-11-20T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/neurotrope-doses-last-alzheimers-disease-patient-in-phase-iia-trial-of-bryostatin-1-211114-4448225/ 2014-11-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/navideas-sentinel-lymph-node-detection-agent-lymphoseek-gets-marketing-approval-in-europe-211114-4446474/ 2014-11-21T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/axim-to-build-manufacturing-facility-for-hemp-based-products-in-netherlands-211114-4446566/ 2014-11-21T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-and-regenerons-atopic-dermatitis-drug-receives-fda-breakthrough-therapy-status-211114-4446698/ 2014-11-21T02:15:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-purdue-pharmas-hysingla-er-with-abuse-deterrent-properties-211114-4446746/ 2014-11-21T02:18:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-expands-capabilities-in-asia-with-new-manufacturing-facility-in-singapore-211114-4446770/ 2014-11-21T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/novavax-rsv-f-protein-nanoparticle-vaccine-gets-fda-fast-track-status-211114-4446859/ 2014-11-21T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-recalls-one-lot-of-highly-concentrated-potassium-chloride-injection-in-us-211114-4446949/ 2014-11-21T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/highland-therapeutics-receives-second-notice-of-allowance-for-patent-on-lead-product-211114-4446959/ 2014-11-21T06:54:00+00:00 https://www.pharmaceutical-business-review.com/news/heptares-orphan-disease-program-awarded-grant-from-uk-biomedical-catalyst-211114-4446972/ 2014-11-21T06:54:00+00:00 https://www.pharmaceutical-business-review.com/news/apellis-pharmaceuticals-to-acquire-potentia-pharmaceuticals-211114-4446980/ 2014-11-21T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-launches-otc-fexofenadine-hydrochloride-60-g-and-pseudoephedrine-hydrochloride-120mg-extended-release-tablets-211114-4446967/ 2014-11-21T07:01:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-chmp-issues-positive-opinion-for-boehringers-nintedanib-to-treat-ipf-241114-4447810/ 2014-11-24T00:02:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisks-victoza-gets-chmp-positive-opinion-to-treat-adults-with-type-2-diabetes-241114-4448189/ 2014-11-24T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/genzymes-cerdelga-secures-european-chmp-positive-opinion-241114-4448250/ 2014-11-24T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/yabao-mrc-technology-to-develop-new-therapeutics-in-china-for-parkinsons-disease-241114-4448312/ 2014-11-24T03:33:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-plans-200m-investment-to-expand-frederick-biologics-manufacturing-center-241114-4448369/ 2014-11-24T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/chmp-grants-positive-opinions-of-abbvies-viekirax-exviera-to-treat-chronic-hepatitis-c-241114-4448659/ 2014-11-24T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/orexigen-gets-allowance-from-uspto-for-new-us-patent-for-contrave-241114-4448693/ 2014-11-24T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/zs-pharma-reports-results-from-phase-iii-study-of-zs-9-in-patients-with-hyperkalemia-241114-4448666/ 2014-11-24T06:13:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-launches-antiepileptic-drug-fycompa-in-hong-kong-241114-4448687/ 2014-11-24T06:13:00+00:00 https://www.pharmaceutical-business-review.com/news/intra-cellular-therapies-reports-positive-phase-iii-iti-007-trial-results-241114-4448932/ 2014-11-24T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/xenetic-completes-dosing-patients-in-phase-ii-myeloxen-trial-to-treat-multiple-sclerosis-241114-4448985/ 2014-11-24T08:25:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-duaklir-genuair-gets-marketing-approval-in-europe-for-copd-251114-4449147/ 2014-11-24T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-novartis-signifor-to-treat-patients-with-acromegaly-251114-4449277/ 2014-11-25T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/sevion-avidity-nanomedicines-enter-research-agreement-for-chimerasome-251114-4449823/ 2014-11-25T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-submits-patent-challenge-for-generic-version-of-aveed-injection-251114-4450073/ 2014-11-25T07:09:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-five-prime-to-evaluate-nivolumab-and-fpa008-combination-in-six-tumor-types-251114-4450300/ 2014-11-25T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/celgene-gets-positive-chmp-opinion-for-otezla-to-treat-psoriasis-and-psoriatic-arthritis-251114-4450196/ 2014-11-25T07:19:00+00:00 https://www.pharmaceutical-business-review.com/news/omnicare-and-mckesson-expand-distribution-agreement-251114-4450187/ 2014-11-25T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-newlink-genetics-ink-licensing-deal-for-investigational-ebola-vaccine-251114-4450410/ 2014-11-25T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/transposagen-enters-into-research-collaboration-with-janssen-for-allogeneic-car-t-cell-therapies-251114-4450173/ 2014-11-25T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvilex-forms-diabetes-consortium-to-develop-treatment-for-insulin-dependent-diabetes-251114-4450180/ 2014-11-25T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/biomarin-agrees-to-acquire-prosensa-251114-4450205/ 2014-11-25T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-launches-generic-version-of-astellas-protopic-ointment-01-and-003-251114-4450160/ 2014-11-25T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-terminates-all-company-sponsored-trials-of-rilotumumab-in-advanced-gastric-cancer-251114-4450449/ 2014-11-25T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-extends-review-period-for-novartis-multiple-myeloma-investigational-compound-lbh589-261114-4450655/ 2014-11-26T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-and-astrazeneca-report-positive-phase-iii-trial-results-of-plaque-psoriasis-drug-brodalumab-261114-4451162/ 2014-11-26T03:27:00+00:00 https://www.pharmaceutical-business-review.com/news/inergetics-advisory-board-meets-to-discuss-launch-preparations-for-new-cbd-based-supplement-line-261114-4451077/ 2014-11-26T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/trimel-announces-issuance-of-additional-patent-covering-natesto-261114-4451088/ 2014-11-26T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-gets-fda-approval-for-onexton-gel-to-treat-acne-vulgaris-261114-4451085/ 2014-11-26T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/paragon-wins-nih-contract-to-design-and-scale-up-manufacturing-of-rhe-selectin-protein-261114-4451081/ 2014-11-26T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-confirms-first-to-file-patent-challenge-relating-to-brevibloc-261114-4451094/ 2014-11-26T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-grants-orphan-designation-for-apitopes-atx-f8-117-to-treat-haemophilia-a-261114-4451522/ 2014-11-26T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/alexions-soliris-secures-orphan-drug-designation-odd-in-japan-to-treat-neuromyelitis-optica-261114-4451471/ 2014-11-26T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/oxford-and-menarini-begins-first-in-human-trial-of-leukemia-drug-obt357-261114-4451756/ 2014-11-26T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/synthon-doses-first-patient-in-phase-i-trial-of-cancer-drug-syd985-261114-4451694/ 2014-11-26T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/lillys-trulicity-solution-for-injection-gets-european-approval-to-treat-type-2-diabetes-261114-4451796/ 2014-11-26T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-nice-recommends-new-drug-nalmefene-to-control-alcohol-consumption-271114-4453419/ 2014-11-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-opens-new-packaging-facility-at-uks-hatfield-production-plant-271114-4453425/ 2014-11-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-reports-positive-phase-i-trial-results-of-ebola-vaccine-candidate-271114-4452260/ 2014-11-27T00:12:00+00:00 https://www.pharmaceutical-business-review.com/news/us-ftc-approves-gsks-proposed-acquisition-of-novartis-vaccine-business-271114-4452566/ 2014-11-27T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-gets-fda-complete-response-letter-for-hepatitis-c-drug-daclatasvir-271114-4452768/ 2014-11-27T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/cancer-research-uk-illumina-sign-sequencing-technology-deal-for-lung-cancer-trial-271114-4453356/ 2014-11-27T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-reports-positive-results-from-phase-i-trial-of-caplacizumab-271114-4453412/ 2014-11-27T08:17:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-submits-nda-for-yondelis-to-fda-to-treat-advanced-soft-tissue-sarcoma-271114-4453237/ 2014-11-27T09:16:00+00:00 https://www.pharmaceutical-business-review.com/news/arch-biopartners-completes-clinical-development-plan-for-metamx-271114-4453245/ 2014-11-27T09:18:00+00:00 https://www.pharmaceutical-business-review.com/news/uc-san-francisco-oncosec-medical-to-evaluate-investigational-combination-of-immunopulse-and-anti-pd-1-treatment-271114-4453224/ 2014-11-27T09:20:00+00:00 https://www.pharmaceutical-business-review.com/news/cell-medx-acquires-proprietary-technology-to-treat-diabetes-and-related-ailments-271114-4453251/ 2014-11-27T09:24:00+00:00 https://www.pharmaceutical-business-review.com/news/dynavax-regains-complete-rights-to-tlr-79-inhibitor-dv1179-281114-4454733/ 2014-11-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-gets-eu-marketing-approval-for-lung-cancer-drug-vargatef-281114-4453603/ 2014-11-27T23:47:00+00:00 https://www.pharmaceutical-business-review.com/news/recipharm-acquires-flamel-technologies-facility-in-france-281114-4453986/ 2014-11-28T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/prescription-heroin-offered-to-addicts-in-vancouver-outside-of-clinical-trial-281114-4454065/ 2014-11-28T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-secures-new-grants-in-support-of-ending-mother-to-child-transmission-of-hiv-281114-4453980/ 2014-11-28T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/vivus-gets-two-additional-us-patents-from-uspto-for-qsymia-281114-4453964/ 2014-11-28T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/carenet-joins-indegene-partnership-network-to-accelerate-growth-in-japanese-markets-281114-4454081/ 2014-11-28T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/new-study-shows-immunocal-spplementation-increases-muscle-strength-in-elderly-adults-281114-4453973/ 2014-11-28T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/nice-supports-commissioning-of-alexions-soliris-to-treat-ahus-281114-4454529/ 2014-11-28T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/avanirs-avp-825-nda-gets-fda-complete-response-letter-281114-4454456/ 2014-11-28T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/nordic-nanovector-affibody-to-develop-new-radio-immunotherapies-for-multiple-myeloma-281114-4454490/ 2014-11-28T07:09:00+00:00 https://www.pharmaceutical-business-review.com/news/hovione-submits-first-ind-application-to-fda-for-minocycline-gel-281114-4454406/ 2014-11-28T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-launches-generic-exforge-hct-tablets-in-us-011214-4456739/ 2014-11-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-launches-generic-version-of-intuniv-011214-4456747/ 2014-11-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-awards-147m-new-grants-to-strengthen-hiv-related-services-in-five-sub-saharan-countries-011214-4456751/ 2014-11-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-grants-accelerated-assessment-to-novartis-lcz696-for-heart-failure-011214-4454936/ 2014-11-30T23:59:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-partners-with-cancer-research-uk-for-new-cancer-medicines-011214-4455209/ 2014-12-01T03:04:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-ucb-to-jointly-commercialize-epilepsy-drug-lacosamide-in-japan-011214-4455287/ 2014-12-01T03:21:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsens-sbla-for-dysport-gets-fda-acceptance-011214-4455420/ 2014-12-01T04:19:00+00:00 https://www.pharmaceutical-business-review.com/news/the-medicines-patent-pool-signs-licensing-deal-with-abbvie-for-hiv-paediatric-formulations-011214-4455596/ 2014-12-01T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/mercks-consumer-health-division-sparks-debate-on-future-of-otc-sector011214-4455609/ 2014-12-01T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/alimera-sciences-enters-into-agreement-with-deerfield-management-for-50m-financing-011214-4455617/ 2014-12-01T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-pharmaceutical-optimizes-its-global-production-network-011214-4455893/ 2014-12-01T08:08:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-opens-new-suzhou-production-facility-in-china-011214-4455941/ 2014-12-01T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-lilly-start-phase-iiiii-trial-of-azd3293-in-alzheimers-disease-patients-021214-4456287/ 2014-12-02T00:56:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-acquires-baxter-vaccine-business-for-635m-021214-4456377/ 2014-12-02T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/unum-therapeutics-begins-phase-i-trial-of-attck20-combination-therapy-021214-4456698/ 2014-12-02T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/tg-therapeutics-starts-phase-i-trial-of-tgr-1202-and-ibrutinib-combination-in-cll-and-mcl-patients-021214-4456763/ 2014-12-02T03:17:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-priority-review-for-eylea-injection-to-treat-diabetic-retinopathy-in-dme-patients-021214-4456814/ 2014-12-02T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/immunocellular-gets-ema-positive-regulatory-feedback-on-advancing-ict-107-to-phase-iii-program-021214-4456692/ 2014-12-02T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-provides-update-on-fingolimod-phase-iii-trial-in-primary-progressive-ms-021214-4456728/ 2014-12-02T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/galmed-completes-analysis-of-pharmacokinetic-study-of-aramchol-in-healthy-volunteers-021214-4456718/ 2014-12-02T04:15:00+00:00 https://www.pharmaceutical-business-review.com/news/momentas-necuparanib-receives-fda-fast-track-status-to-treat-metastatic-pancreatic-cancer-021214-4456735/ 2014-12-02T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/aeterna-zentaris-and-sinopharm-a-think-ink-deal-for-zoptarelin-doxorubicin-in-china-021214-4456700/ 2014-12-02T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/oncomed-starts-dosing-in-phase-ii-trial-of-lung-cancer-drug-tarextumab-021214-4457236/ 2014-12-02T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-seeks-ema-approval-for-imbruvica-to-include-waldenstrms-macroglobulinemia-treatment-021214-4457147/ 2014-12-02T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/oncolytics-seeks-fda-orphan-drug-status-for-reolysin-to-treat-pancreatic-and-ovarian-cancers-031214-4458639/ 2014-12-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lpath-completes-enrollment-in-phase-2-clinical-trial-of-isonep-for-wet-amd-031214-4459442/ 2014-12-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/otsuka-to-buy-avanir-pharma-for-35bn-031214-4457755/ 2014-12-03T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-gets-fda-approval-for-generic-version-of-pennsaid-15-ww-031214-4458056/ 2014-12-03T03:01:00+00:00 https://www.pharmaceutical-business-review.com/news/chromadex-licenses-patent-rights-from-mississippi-university-for-microalgae-technology-031214-4458093/ 2014-12-03T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-astellas-prostate-cancer-drug-enzalutamide-031214-4458157/ 2014-12-03T03:05:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-orders-new-warnings-on-otc-acetaminophen-drugs-031214-4458119/ 2014-12-03T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/qualitas-health-meets-major-commercial-milestone-with-almega-pl-031214-4458128/ 2014-12-03T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/meridian-life-science-gets-sbir-ii-by-cdc-to-develop-rotavirus-vaccine-031214-4458123/ 2014-12-03T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/foundation-medicine-and-flatiron-health-to-develop-data-platform-to-accelerate-precision-medicine-for-cancer-031214-4458135/ 2014-12-03T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/tesaro-anaptysbio-expand-immuno-oncology-collaboration-for-new-bispecific-antibody-candidate-031214-4458114/ 2014-12-03T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-sanofis-priftin-to-treat-latent-tuberculosis-infection-031214-4458572/ 2014-12-03T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/zosano-and-lilly-agree-to-develop-zp-pth-product-candidate-for-osteoporosis-031214-4458617/ 2014-12-03T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/biopharmx-submits-pre-ind-meeting-request-to-fda-for-its-topical-acne-solution-041214-4460656/ 2014-12-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/jazz-starts-enrolling-patients-in-phase-iii-xyrem-pediatric-narcolepsy-trial-041214-4458865/ 2014-12-03T23:36:00+00:00 https://www.pharmaceutical-business-review.com/news/first-ms-patients-treated-with-genzymes-lemtrada-in-us-041214-4458864/ 2014-12-03T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/unilife-to-use-depot-ject-delivery-system-with-approved-ocular-injection-drug-041214-4459433/ 2014-12-04T02:21:00+00:00 https://www.pharmaceutical-business-review.com/news/catalent-and-valerion-partner-to-bring-new-treatments-for-orphan-genetic-disorders-to-market-041214-4459484/ 2014-12-04T02:41:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-awards-nine-new-grants-to-fight-against-hepatitis-b-and-c-in-china-and-india-041214-4459974/ 2014-12-04T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-amgens-blincyto-to-treat-relapsed-or-refractory-b-cell-precursor-all-041214-4459995/ 2014-12-04T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-shed-several-us-sales-and-research-jobs-041214-4460122/ 2014-12-04T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/monash-university-60p-australia-to-develop-fenretinide-drug-for-dengue-fever-041214-4459950/ 2014-12-04T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-finds-no-evidence-of-serious-events-in-novartis-fluad-vaccine-041214-4460155/ 2014-12-04T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/world-anti-doping-agency-signs-collaboration-agreement-with-pfizer-041214-4460130/ 2014-12-04T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-submits-marketing-authorization-application-for-bay-81-8973-in-europe-051214-4461073/ 2014-12-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/five-prime-therapeutics-starts-dosing-fpa144-in-phase-1-clinical-trial-051214-4461254/ 2014-12-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/kkr-to-acquire-minority-stake-in-arbor-pharmaceuticals-051214-4460392/ 2014-12-04T23:21:00+00:00 https://www.pharmaceutical-business-review.com/news/array-biopharma-to-regain-global-rights-for-binimetinib-cancer-drugfrom-novartis-051214-4460182/ 2014-12-05T00:24:00+00:00 https://www.pharmaceutical-business-review.com/news/first-booster-ebola-vaccine-trials-begin-at-oxford-university-051214-4460534/ 2014-12-05T00:31:00+00:00 https://www.pharmaceutical-business-review.com/news/geneuro-servier-partner-to-develop-drug-for-causal-factor-of-multiple-sclerosis-051214-4460595/ 2014-12-05T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/johnson-matthey-completes-acquisition-of-pharmaceutical-manufacturing-facility-in-uk-051214-4460661/ 2014-12-05T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/nsf-grants-first-awards-to-advance-fundamental-ebola-research-051214-4460695/ 2014-12-05T01:52:00+00:00 https://www.pharmaceutical-business-review.com/news/national-cancer-institute-selects-mriglobal-to-produce-hpv-vaccine-051214-4460732/ 2014-12-05T02:31:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-mylans-ndas-for-two-dosages-of-abacavirlamivudine-tablets-051214-4460789/ 2014-12-05T03:06:00+00:00 https://www.pharmaceutical-business-review.com/news/aliz-pharma-acquires-exclusive-worldwide-rights-on-new-peptide-to-tackle-bone-diseases-051214-4460938/ 2014-12-05T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-to-end-license-agreement-with-janssen-for-asp015k-inhibitor-051214-4460885/ 2014-12-05T05:18:00+00:00 https://www.pharmaceutical-business-review.com/news/kempharm-gets-notice-of-allowance-from-uspto-for-nme-prodrug-of-methylphenidate-081214-4462627/ 2014-12-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/basilea-launches-zevtera-in-germany-081214-4462649/ 2014-12-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-in-talks-to-acquire-cubist-pharmaceuticals-for-nearly-8bn-081214-4461549/ 2014-12-07T23:36:00+00:00 https://www.pharmaceutical-business-review.com/news/cornerstone-initiates-phase-i-trial-of-lymphoma-drug-candidate-cpi-613-081214-4462382/ 2014-12-08T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/oncosec-reports-positive-six-month-results-from-phase-ii-trial-of-melanoma-drug-081214-4462433/ 2014-12-08T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-takeda-report-phase-iii-aethera-clinical-trial-data-from-adcetris-081214-4462131/ 2014-12-08T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-releases-results-from-phase-ii-study-of-venetoclax-in-acute-myelogenous-leukemia-081214-4462142/ 2014-12-08T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-reports-positive-results-from-phase-ib-trial-of-opdivo-081214-4462119/ 2014-12-08T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-reports-positive-clinical-data-from-leukemia-drug-ctl019-in-children-and-young-adults-081214-4462154/ 2014-12-08T06:58:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-reports-positive-results-from-phase-iii-trial-of-novoeight-in-haemophilia-a-people-081214-4462163/ 2014-12-08T06:59:00+00:00 https://www.pharmaceutical-business-review.com/news/biomarins-vimizim-gets-approval-in-australia-to-treat-morquio-a-syndrome-081214-4462556/ 2014-12-08T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/sunovion-seeks-fda-approval-for-aptiom-as-monotherapy-treatment-for-partial-onset-seizures-081214-4462589/ 2014-12-08T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/vaxinnate-begins-phase-ibii-trial-of-quadrivalent-influenza-vaccine-candidate-091214-4463951/ 2014-12-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-agrees-to-buy-cubist-pharmaceuticals-for-95bn-091214-4462909/ 2014-12-09T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-initiates-phase-i-trial-of-melanoma-drug-combination-091214-4463258/ 2014-12-09T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-advaxis-ind-application-to-initiate-phase-iii-combination-prostate-cancer-trial-091214-4463423/ 2014-12-09T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/paxvax-reports-positive-results-from-phase-iii-cholera-vaccine-trial-091214-4463503/ 2014-12-09T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/spark-therapeutics-pfizer-to-develop-new-treatment-paradigm-for-hemophilia-b-091214-4463612/ 2014-12-09T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-anthem-and-healthcore-partner-to-improve-health-outcomes-091214-4463688/ 2014-12-09T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/novabay-signs-distribution-agreement-with-the-biopharm-group-091214-4463935/ 2014-12-09T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-amgens-xgeva-to-treat-hypercalcemia-091214-4463931/ 2014-12-09T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/acura-receives-additional-us-patent-for-abuse-deterrent-drug-formulations-091214-4463940/ 2014-12-09T08:12:00+00:00 https://www.pharmaceutical-business-review.com/news/iteos-enters-into-license-and-collaboration-deal-with-pfizer-091214-4463945/ 2014-12-09T08:15:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-launches-new-formulation-of-lixiana-60-mg-tablets-in-japan-091214-4463926/ 2014-12-09T08:18:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-moventig-gets-european-marketing-authorization-for-opioid-induced-constipation-101214-4464184/ 2014-12-10T00:05:00+00:00 https://www.pharmaceutical-business-review.com/news/puramed-enters-into-distribution-deal-with-fastfunds-for-migraine-relief-drug-101214-4464587/ 2014-12-10T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/biopharmx-launches-otc-pill-violet-iodine-for-relief-of-premenstrual-breast-discomfort-101214-4464628/ 2014-12-10T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-monash-enter-research-collaboration-to-tackle-human-gastrointestinal-diseases-101214-4464681/ 2014-12-10T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-releases-positive-phase-i-data-of-idarucizumab-in-renally-impaired-patients-101214-4464799/ 2014-12-10T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/endo-completes-acquisition-of-rights-to-natesto-testosterone-nasal-gel-101214-4464730/ 2014-12-10T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/can-fite-to-begin-development-program-of-next-generation-drug-cf602-101214-4464746/ 2014-12-10T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-filing-of-aprecias-nda-for-first-product-using-zipdose-technology-101214-4465202/ 2014-12-10T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/vital-connect-medidata-partner-to-enhance-clinical-trials-with-continuous-vital-sign-monitoring-101214-4464716/ 2014-12-10T08:22:00+00:00 https://www.pharmaceutical-business-review.com/news/ignyta-receives-who-approval-of-nonproprietary-name-entrectinib-for-rxdx-101-101214-4464738/ 2014-12-10T08:26:00+00:00 https://www.pharmaceutical-business-review.com/news/mast-announces-plans-for-development-of-vepoloxamer-in-heart-failure-101214-4464698/ 2014-12-10T08:28:00+00:00 https://www.pharmaceutical-business-review.com/news/multicell-technologies-files-new-antibody-drug-conjugate-patent-application-111214-4465834/ 2014-12-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/brazil-approves-biomarins-vimizim-to-treat-morquio-a-syndrome-111214-4465512/ 2014-12-11T00:19:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-introduces-celebrex-generic-version-111214-4466120/ 2014-12-11T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-ono-and-kyowa-hakko-enter-immuno-oncology-clinical-collaboration-111214-4465826/ 2014-12-11T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-arcas-rnapc2-as-potential-treatment-for-ebola-111214-4466244/ 2014-12-11T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/avid-starts-expansion-of-cgmp-manufacturing-capacity-111214-4466287/ 2014-12-11T06:45:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-bostons-ind-to-begin-clinical-trial-of-bti-320-to-treat-type-2-diabetes-and-weight-loss-111214-4466462/ 2014-12-11T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/futureworld-receives-major-shipment-of-cbd-oil-for-cbd-based-pharmaceuticals-nutraceutical-111214-4465818/ 2014-12-11T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-and-dndi-to-develop-an-innovative-oral-treatment-for-human-river-blindness-111214-4465822/ 2014-12-11T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/axxess-pharma-tapout-fitness-enter-exclusive-alliance-to-supply-gyms-with-tapout-products-111214-4465840/ 2014-12-11T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/navidea-forms-macrophage-therapeutics-business-unit-to-explore-therapeutic-applications-of-manocept-111214-4465829/ 2014-12-11T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-reports-positive-data-investigating-use-of-pembrolizumab-in-patients-with-advanced-triple-negative-breast-cancer-111214-4465849/ 2014-12-11T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-usaid-to-expand-access-to-anti-multidrug-resistant-tuberculosis-compound-121214-4468444/ 2014-12-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/glaxosmithkline-seeks-ema-approval-for-extended-indication-for-ambrisentan-to-treat-pah-121214-4466859/ 2014-12-12T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-starts-phase-iii-trial-of-revusiran-to-treat-fac-patients-121214-4467061/ 2014-12-12T02:25:00+00:00 https://www.pharmaceutical-business-review.com/news/immunovaccine-receives-fda-fast-track-status-for-dpx-survivac-to-treat-ovarian-cancer-121214-4468436/ 2014-12-12T02:28:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-begins-us-recall-of-two-lots-of-sodium-chloride-injection-usp-121214-4467413/ 2014-12-12T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/wilshire-confirms-first-to-file-patent-challenge-relating-to-lastacaft-121214-4467422/ 2014-12-12T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/cystic-fibrosis-foundation-shire-partner-to-develop-new-cf-treatment-121214-4467405/ 2014-12-12T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/sunovion-reports-positive-results-from-first-placebo-controlled-trial-of-dasotraline-in-adhd-patients-121214-4467432/ 2014-12-12T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-launches-generic-robaxin-injection-121214-4467438/ 2014-12-12T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/pieris-begins-phase-i-trial-of-anemia-drug-compound-prs-080-121214-4467730/ 2014-12-12T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/voyager-massbiologics-enter-strategic-collaboration-for-viral-vector-manufacturing-121214-4467816/ 2014-12-12T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/x-chem-alexion-to-discover-new-therapies-for-severe-and-ultra-rare-disorders-121214-4467758/ 2014-12-12T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/lakewood-amedex-seeks-fda-approval-for-phase-iiia-trial-of-nu-3-for-diabetic-foot-infections-121214-4467791/ 2014-12-12T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-lillys-cyramza-to-treat-aggressive-non-small-cell-lung-cancer-151214-4468197/ 2014-12-15T00:17:00+00:00 https://www.pharmaceutical-business-review.com/news/jazz-begins-rolling-nda-submission-for-defibrotide-to-treat-severe-hepatic-vod-151214-4468422/ 2014-12-15T02:07:00+00:00 https://www.pharmaceutical-business-review.com/news/karyopharm-doses-first-patient-in-phase-iib-trial-of-selinexor-to-treat-dlbcl-151214-4468644/ 2014-12-15T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-sanofi-pasteurs-sbla-for-fluzone-intradermal-quadrivalent-vaccine-for-adults-151214-4468463/ 2014-12-15T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/array-biopharma-grants-license-to-oncothyreon-for-ont-380-151214-4468607/ 2014-12-15T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/twi-gets-approval-for-protocol-of-phase-ii-trial-of-ac-201-in-us-and-taiwan-151214-4468524/ 2014-12-15T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/chemocentryx-reports-positive-results-from-phase-ii-diabetic-nephropathy-trial-of-ccx140-151214-4468450/ 2014-12-15T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/mettrum-gets-health-canada-license-at-its-agripharm-facility-151214-4468457/ 2014-12-15T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-two-higher-dosage-strengths-of-orexos-zubsolv-151214-4468462/ 2014-12-15T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/pacira-pharmaceuticals-announces-changes-to-exparel-label-151214-4468465/ 2014-12-15T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mercks-hpv-vaccine-gardasil9-151214-4468479/ 2014-12-15T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-releases-positive-results-from-two-breast-cancer-trials-of-afatinib-151214-4469051/ 2014-12-15T07:27:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-develop-and-commercialize-opkos-long-acting-human-growth-hormone-161214-4469529/ 2014-12-16T00:08:00+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-seeks-japans-approval-for-combination-drug-to-treat-hiv-161214-4469564/ 2014-12-16T03:26:00+00:00 https://www.pharmaceutical-business-review.com/news/prothenas-al-amyloidosis-treatment-neod001-gets-fda-fast-track-status-161214-4469847/ 2014-12-16T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/sorrento-nantworks-to-jointly-develop-next-generation-cancer-immunotherapies-161214-4469871/ 2014-12-16T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-gets-fda-clearance-to-begin-phase-iii-trial-of-combination-cancer-therapy-161214-4469731/ 2014-12-16T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-to-divest-vero-cell-vaccines-platform-to-nanotherapeutics-161214-4469880/ 2014-12-16T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/microchips-completes-development-clinical-demonstration-of-drug-delivery-platform-161214-4469887/ 2014-12-16T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-reports-positive-phase-ii-paloma-1-trial-of-palbociclib-161214-4469891/ 2014-12-16T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-will-appeal-injunction-requiring-continued-distribution-of-namenda-ir-161214-4469895/ 2014-12-16T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/american-regents-injectafer-assigned-j-code-by-centers-for-medicare-medicaid-services-161214-4469901/ 2014-12-16T05:18:00+00:00 https://www.pharmaceutical-business-review.com/news/collegium-seeks-fda-approval-for-xtampza-er-to-treat-chronic-pain-161214-4469635/ 2014-12-16T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-enrolls-first-patient-in-phase-iii-re-spect-esus-trial-of-dabigatran-161214-4470561/ 2014-12-16T07:31:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-signifor-lar-obtains-fda-approval-to-treat-acromegaly-171214-4470895/ 2014-12-16T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/new-european-consortium-to-help-advance-development-of-gsknih-ebola-vaccine-candidate-171214-4470952/ 2014-12-17T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/nice-recommends-boehringers-pradaxa-to-treat-and-prevent-recurrence-of-dvt-and-pe-171214-4471207/ 2014-12-17T03:16:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-ipsens-somatuline-depot-injection-to-treat-gep-nets-171214-4471221/ 2014-12-17T03:16:00+00:00 https://www.pharmaceutical-business-review.com/news/csl-behring-seeks-fda-approval-for-rix-fp-to-treat-hemophilia-b-patients-171214-4471258/ 2014-12-17T04:01:00+00:00 https://www.pharmaceutical-business-review.com/news/yew-bio-pharm-to-enter-us-health-supplement-market-with-two-agaric-polysaccharide-products-171214-4471276/ 2014-12-17T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/durect-grants-worldwide-rights-of-saber-ophthalmology-product-to-santen-171214-4471348/ 2014-12-17T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-strategics-md-anderson-to-conduct-phase-iiia-trial-of-leukemia-drug-e6201-171214-4471507/ 2014-12-17T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/novogen-announces-breakthrough-discovery-melanoma-treatment-171214-4471280/ 2014-12-17T08:13:00+00:00 https://www.pharmaceutical-business-review.com/news/ppd-ert-partner-to-improve-drug-development-171214-4471284/ 2014-12-17T08:15:00+00:00 https://www.pharmaceutical-business-review.com/news/portage-further-validates-new-proprietory-cell-permeable-peptide-platform-technology-171214-4471292/ 2014-12-17T08:17:00+00:00 https://www.pharmaceutical-business-review.com/news/lightlake-enters-into-license-agreement-with-adapt-pharma-operations-171214-4471295/ 2014-12-17T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-begins-phase-ii-trial-of-pf-06252616-to-treat-duchenne-muscular-dystrophy-181214-4472077/ 2014-12-18T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/ossianix-and-lundbeck-agree-to-research-collaboration-expansion-on-cns-therapeutics-181214-4472264/ 2014-12-18T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-novartis-to-develop-and-commercialize-israeli-sourced-drug-candidates-181214-4472276/ 2014-12-18T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/hedgepath-gets-fda-nod-to-begin-proposed-cancer-drug-development-181214-4471313/ 2014-12-18T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-for-filing-apotexs-biosimilar-application-for-pegfilgrastim-181214-4472503/ 2014-12-18T06:13:00+00:00 https://www.pharmaceutical-business-review.com/news/halozyme-janssen-to-develop-and-commercialize-products-using-enhanze-technology-181214-4472603/ 2014-12-18T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/clementia-begins-natural-history-trial-in-fop-patients-181214-4472481/ 2014-12-18T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/cannapharmarx-pharmadirections-to-start-research-discovery-program-in-cannabinoid-science-181214-4472545/ 2014-12-18T07:01:00+00:00 https://www.pharmaceutical-business-review.com/news/bioblast-receives-notice-of-patent-issuance-for-new-fusion-protein-based-platform-to-treat-friedrichs-ataxia-181214-4472552/ 2014-12-18T07:04:00+00:00 https://www.pharmaceutical-business-review.com/news/iodine-launches-cold-and-flu-app-to-help-smart-consumers-find-best-otc-options-for-their-symptoms-181214-4472559/ 2014-12-18T07:04:00+00:00 https://www.pharmaceutical-business-review.com/news/nutrafuels-receives-purchase-order-from-rc-taylor-distributing-181214-4472563/ 2014-12-18T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/icardiac-technologies-iq-csrc-study-shows-potential-for-faster-drug-development-181214-4472568/ 2014-12-18T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/alexza-amends-autoliv-agreement-for-heat-packages-used-in-aadasuve-191214-4474732/ 2014-12-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cerulean-doses-first-patient-in-phase-iiia-trial-of-crlx301-to-treat-advanced-solid-tumors-181214-4472569/ 2014-12-18T23:40:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-canada-secures-rights-of-hypertension-drugs-edarbi-and-edarbyclor-from-takeda-181214-4472634/ 2014-12-18T23:40:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-lynparza-gets-european-approval-to-treat-brca-mutated-ovarian-cancer-191214-4473370/ 2014-12-18T23:53:00+00:00 https://www.pharmaceutical-business-review.com/news/kcr-buys-ukrainian-cro-axis-project-portfolio-191214-4473393/ 2014-12-19T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-reports-positive-results-from-phase-iii-trial-of-shingles-candidate-vaccine-191214-4473462/ 2014-12-19T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-files-bla-for-bay-81-8973-to-treat-hemophilia-a-in-adults-and-children-191214-4473475/ 2014-12-19T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-reports-positive-results-from-phase-iii-trial-of-pregabalin-191214-4473635/ 2014-12-19T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/biocryst-begins-opus-2-clinical-trial-of-bcx4161-to-treat-patients-with-hereditary-angioedema-191214-4473640/ 2014-12-19T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/enumeral-merck-to-predict-clinical-drug-response-with-human-driven-immune-profiling-platform-191214-4473654/ 2014-12-19T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/aldeyra-therapeutics-submits-fda-ind-filing-for-noninfectious-anterior-uveitis-191214-4473665/ 2014-12-19T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-to-acquire-swiss-biotechnology-firm-oncoethix-191214-4473483/ 2014-12-19T02:13:00+00:00 https://www.pharmaceutical-business-review.com/news/bethel-nutritional-recalls-slim-k-capsules-due-to-undeclared-drug-ingredients-221214-4476534/ 2014-12-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-to-nuvilex-for-pancreatic-cancer-treatment-221214-4476536/ 2014-12-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/european-medicines-agency-recommends-janssen-velcade-for-treatment-of-mantle-cell-lymphoma-221214-4474087/ 2014-12-22T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-laboratories-buys-habitrol-brand-from-novartis-221214-4474441/ 2014-12-22T03:13:00+00:00 https://www.pharmaceutical-business-review.com/news/msd-launches-posaconazole-concentrate-for-solution-for-iv-in-uk-221214-4474431/ 2014-12-22T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/ups-announces-acquisition-of-poltraf-221214-4474605/ 2014-12-22T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/cardinal-health-agrees-to-contract-manufacture-bayers-xofigo-221214-4474541/ 2014-12-22T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/fujifilm-diosynth-acquires-kalon-biotherapeutics-221214-4474595/ 2014-12-22T07:19:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-jazzs-intravenous-administration-of-erwinaze-221214-4474516/ 2014-12-22T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/sst-signs-partnership-agreement-with-an-otc-firm-for-us-commercial-rights-to-topical-ibuprofen-221214-4475135/ 2014-12-22T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/newlink-genetics-merck-receive-grant-to-manufacture-ebola-vaccine-candidate-221214-4475169/ 2014-12-22T08:08:00+00:00 https://www.pharmaceutical-business-review.com/news/biocrysts-rapivab-receives-fda-approval-to-treat-aacute-uncomplicated-influenza-221214-4475177/ 2014-12-22T08:14:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-seeks-fda-approval-for-additional-indication-of-eltrombopag-to-treat-itp-231214-4475531/ 2014-12-23T00:19:00+00:00 https://www.pharmaceutical-business-review.com/news/prometic-enters-into-strategic-alliance-with-generium-pharmaceuticals-231214-4475803/ 2014-12-23T02:32:00+00:00 https://www.pharmaceutical-business-review.com/news/can-fite-starts-dosing-in-phase-ii-trial-of-cf102-to-treat-hepatocellular-carcinoma-231214-4476275/ 2014-12-23T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/tekmira-signs-tkm-ebola-guinea-clinical-trial-agreement-with-oxford-university-231214-4476299/ 2014-12-23T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmacyclics-announces-update-on-imbruvica-waldenstroms-macroglobulinemia-wm-submission-231214-4475813/ 2014-12-23T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/epivax-enters-license-deal-with-novozymes-to-advance-pioneering-treatment-of-autoimmune-diseases-231214-4475824/ 2014-12-23T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/oncolytics-announces-filing-for-orphan-designation-with-the-ema-for-pancreatic-and-ovarian-cancers-231214-4475829/ 2014-12-23T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/bio-path-starts-development-of-follicular-lymphoma-drug-liposomal-bcl-2-231214-4476525/ 2014-12-23T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/twi-biotechnology-gets-notice-of-patent-allowance-for-ac-201-for-type-ii-diabetes-in-china-231214-4475835/ 2014-12-23T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-bristol-myers-opdivo-to-treat-metastatic-melanoma-231214-4476568/ 2014-12-23T09:01:00+00:00 https://www.pharmaceutical-business-review.com/news/biocryst-gets-fda-approval-for-rapivab-to-treat-acute-uncomplicated-influenza-231214-4476563/ 2014-12-23T09:02:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-enters-diabetes-research-collaboration-with-surrey-university-231214-4476571/ 2014-12-23T09:12:00+00:00 https://www.pharmaceutical-business-review.com/news/roivant-agrees-to-acquire-sb742457-from-glaxosmithkline-241214-4476690/ 2014-12-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/eb-pharma-gets-license-to-assess-tipifarnib-for-hepatitis-delta-virus-infection-241214-4476909/ 2014-12-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biocrysts-bcx4430-antiviral-shows-promise-in-ebola-infected-monkeys-241214-4476940/ 2014-12-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvies-holkira-pak-approved-for-treatment-of-chronic-gt1-hepatitis-c-241214-4476951/ 2014-12-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-for-amarantuss-manf-to-treat-retinitis-pigmentosa-241214-4476970/ 2014-12-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ariad-otsuka-partner-to-commercialize-iclusig-in-japan-and-nine-asian-countries-241214-4476977/ 2014-12-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/selecta-secures-grant-to-develop-svp-immunotherapy-to-treat-hpv-cancers-241214-4477057/ 2014-12-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tevas-granix-injection-gets-fda-approval-for-self-administration-241214-4477071/ 2014-12-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-galdermas-soolantra-cream-for-rosacea-patients-241214-4477081/ 2014-12-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/contrafect-authorized-to-initiate-clinical-trials-of-cf-301-for-mrsa-bloodstream-infections-241214-4477084/ 2014-12-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/medivation-exercises-license-option-for-pidilizumab-241214-4477088/ 2014-12-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/rock-creek-seeks-mhra-approval-to-start-anatabine-citrate-clinical-trials-241214-4476922/ 2014-12-24T02:11:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-and-adamas-receive-fda-approval-for-namzaric-to-treat-dementia-261214-4477716/ 2014-12-26T00:24:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/spectrum-submits-new-drug-application-to-fda-for-ce-melphalan-291214-4478216/ 2014-12-29T00:04:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/gilead-janssen-expand-agreements-to-develop-taf-based-single-tablet-regimens-for-hiv-treatment-301214-4479085/ 2014-12-30T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/hospira-obtains-fda-approval-for-analgesic-dyloject-injection-311214-4479822/ 2014-12-31T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-amag-pharmaceuticals-agree-to-terminate-ferumoxytol-commercialization-agreement-050115-4480910/ 2015-01-05T00:19:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-mhra-accepts-to-review-redhills-marketing-application-for-bekinda-050115-4481084/ 2015-01-05T03:49:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-accepts-sucampos-new-drug-submission-for-constipation-drug-amitiza-050115-4481116/ 2015-01-05T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/knight-therapeutics-to-commercialize-neuraxons-new-pharmaceutical-products-050115-4481138/ 2015-01-05T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/ariad-angelini-to-commercialize-iclusig-in-seven-central-and-eastern-european-countries-050115-4481168/ 2015-01-05T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/alexion-completes-rolling-bla-submission-to-fda-for-asfotase-alfa-to-treat-hypophosphatasia-050115-4481152/ 2015-01-05T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/nephrogenex-announces-positive-results-for-qt-study-of-pyridorin-050115-4481155/ 2015-01-05T04:23:00+00:00 https://www.pharmaceutical-business-review.com/news/tekmira-provides-update-on-tkm-plk1-phase-iii-clinical-trial-050115-4481158/ 2015-01-05T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-issues-voluntary-nationwide-recall-of-virazole-050115-4481162/ 2015-01-05T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/united-therapeutics-inks-deal-with-deka-for-new-remodulin-delivery-system-050115-4481200/ 2015-01-05T08:39:00+00:00 https://www.pharmaceutical-business-review.com/news/aquinox-begins-phase-ii-trial-of-aqx-1125-to-treat-atopic-dermatitis-050115-4481171/ 2015-01-05T08:40:00+00:00 https://www.pharmaceutical-business-review.com/news/synthetic-biologics-begins-dosing-in-phase-ib-trial-of-syn-004-for-prevention-of-c-difficile-infection-050115-4481441/ 2015-01-05T08:40:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-acquires-cmv-vaccine-producer-redvax-060115-4481668/ 2015-01-05T23:55:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-valsartan-tablets-to-treat-hypertension-060114-4482031/ 2015-01-06T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-secures-fda-approval-for-gadavist-injection-060115-4482089/ 2015-01-06T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/leo-pharma-submits-nda-to-us-fda-for-aerosol-foam-to-treat-plaque-psoriasis-060115-4481721/ 2015-01-06T04:04:00+00:00 https://www.pharmaceutical-business-review.com/news/sohm-received-confirmed-orders-for-otc-products-060115-4482240/ 2015-01-06T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/galderma-launches-first-otc-acne-regimen-benzac-acne-solutions-060115-4482225/ 2015-01-06T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-calibr-enter-research-collaboration-for-new-therapies-to-treat-fibrotic-diseases-060115-4482012/ 2015-01-06T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/fennec-completes-patient-enrollment-in-sodium-thiosulfate-phase-iii-siopel-6-study-060115-4482245/ 2015-01-06T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmacyclics-imbruvica-shows-efficacy-in-previously-untreated-and-relapsedrefractory-high-risk-cll-patients-060115-4482252/ 2015-01-06T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-kite-pharma-enter-into-cancer-immunotherapy-collaboration-060115-4482229/ 2015-01-06T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-seeks-fda-approval-to-begin-first-in-human-trial-of-adxs-her2-060115-4482242/ 2015-01-06T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/oncomed-doses-first-patient-in-phase-ia-trial-of-new-anti-dll4vegf-bispecific-antibody-060115-4482643/ 2015-01-06T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/mirati-starts-dosing-in-phase-ii-trial-of-mocetinostat-to-treat-non-hodgkins-lymphoma-070115-4482978/ 2015-01-07T00:08:00+00:00 https://www.pharmaceutical-business-review.com/news/johnson-starts-phase-i-trial-of-ebola-vaccine-regimen-070115-4483041/ 2015-01-07T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-agrees-to-buy-phenexs-fxr-program-to-treat-nash-and-other-liver-diseases-070115-4483281/ 2015-01-07T02:51:00+00:00 https://www.pharmaceutical-business-review.com/news/trevena-begins-phase-iib-trial-of-trv130-to-treat-acute-postoperative-pain-070115-4483304/ 2015-01-07T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/kite-pharma-secures-orphan-drug-designation-in-eu-for-kte-c19-070115-4483472/ 2015-01-07T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/ccam-biotherapeutics-gets-fda-nod-to-begin-phase-i-trial-for-cm-24-to-treat-cancers-070115-4483481/ 2015-01-07T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/gamida-cells-nicord-gets-fda-and-ema-orphan-drug-status-070115-4483488/ 2015-01-07T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/cellular-biomedicine-begins-patient-recruitment-for-cartilage-damage-stem-cell-therapy-clinical-research-study-070115-4483495/ 2015-01-07T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/kalobios-reports-top-line-data-for-phase-ii-trial-of-kb001-a-to-treat-pa-lung-infections-in-cf-patients-070115-4483466/ 2015-01-07T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/pan-european-hta-necessary-director-general-of-efpia-070115-4483656/ 2015-01-07T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-closes-dose-escalation-stage-of-phase-i-trial-of-bl-8040-070115-4483353/ 2015-01-07T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/tobira-gets-fda-fast-track-status-for-cenicriviroc-to-treat-nash-in-liver-fibrosis-patients-070115-4483321/ 2015-01-07T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/kadmon-doses-first-patient-in-phase-ii-trial-of-kd025-to-treat-psoriasis-vulgaris-080115-4483711/ 2015-01-08T00:09:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-to-use-crispr-technology-platforms-for-new-medicines-080115-4484195/ 2015-01-08T00:29:00+00:00 https://www.pharmaceutical-business-review.com/news/genocea-closes-patient-enrollment-in-gen-003-phase-ii-trial-to-treat-genital-herpes-180115-4484427/ 2015-01-08T03:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-to-review-sunovions-snda-of-aptiom-to-treat-partial-onset-seizures-080115-4484377/ 2015-01-08T03:08:00+00:00 https://www.pharmaceutical-business-review.com/news/mundipharmas-targin-gets-positive-decision-in-europe-to-treat-restless-legs-syndrome-080115-4484263/ 2015-01-08T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/reset-therapeutics-enters-into-research-agreement-with-23andme-080115-4484577/ 2015-01-08T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/exelixis-sobi-extend-distribution-agreement-for-cometriq-for-medullary-thyroid-cancer-080115-4484582/ 2015-01-08T03:27:00+00:00 https://www.pharmaceutical-business-review.com/news/cipher-acquires-canadian-commercialization-rights-to-new-antibacterial-compound-ozenoxacin-080115-4484574/ 2015-01-08T03:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mmrf-gns-healthcare-collaborate-to-identify-potential-new-multiple-myeloma-therapies-080115-4484568/ 2015-01-08T03:32:00+00:00 https://www.pharmaceutical-business-review.com/news/sandoz-biosimilar-filgrastim-recommended-for-approval-by-fda-committee-080115-4484589/ 2015-01-08T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/tetragenetics-to-partner-with-medimmune-on-antibody-drug-discovery-research-080115-4484552/ 2015-01-08T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/mirati-begins-dosing-in-phase-ii-trial-of-mocetinostat-to-treat-bladder-cancer-080115-4484490/ 2015-01-08T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/novobiotic-reports-discovery-of-new-antibiotic-teixobactin-090115-4486134/ 2015-01-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyos-anti-clotting-drug-savaysa-gets-fda-approval-090115-4485214/ 2015-01-09T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/karyopharms-selinexor-gets-fda-orphan-drug-status-to-treat-multiple-myeloma-090115-4485498/ 2015-01-09T03:20:00+00:00 https://www.pharmaceutical-business-review.com/news/nuo-therapeutics-inks-licensing-deal-with-rohto-for-aurix-in-japan-090115-4485457/ 2015-01-09T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/versartis-begins-phase-iii-trial-of-vrs-317-in-ghd-children-090115-4485478/ 2015-01-09T03:24:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-impaxs-rytary-to-treat-parkinsons-disease-090115-4485378/ 2015-01-09T03:27:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-reports-positive-phase-iii-results-for-qva149-and-nva237-090115-4485526/ 2015-01-09T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/biostar-signs-joint-research-and-development-deal-with-northwest-university-to-develop-danshensu-yibingzhi-090115-4485537/ 2015-01-09T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/cytrx-reports-positive-interim-phase-ii-aldoxorubicin-results-090115-4485520/ 2015-01-09T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/moderna-launches-new-venture-valera-llc-for-infectious-diseases-090115-4485539/ 2015-01-09T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/highland-therapeutics-announces-issuance-of-two-us-patents-for-hld-200-090115-4485529/ 2015-01-09T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/kyowa-hakko-to-develop-and-commercialize-syndaxs-entinostat-in-japan-and-korea-080115-4484586/ 2015-01-09T11:27:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-and-regenerons-alirocumab-phase-iii-odyssey-trials-meet-primary-endpoints-120115-4486344/ 2015-01-12T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-agrees-to-buy-uks-convergence-pharmaceuticals-120115-4486447/ 2015-01-12T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/proteros-bayer-to-develop-new-cardiovascular-drug-compounds-120115-4486409/ 2015-01-12T02:12:00+00:00 https://www.pharmaceutical-business-review.com/news/precision-nanosystems-arcturus-partner-to-develop-new-rna-medicines-120115-4486559/ 2015-01-12T02:14:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-agrees-to-buy-nps-pharma-for-52bn-120115-4486652/ 2015-01-12T03:10:00+00:00 https://www.pharmaceutical-business-review.com/news/altos-therapeutics-gets-second-issued-patent-covering-new-dopamine-d2d3-antagonists-120115-4486677/ 2015-01-12T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/bionure-national-multiple-sclerosis-society-to-support-development-of-new-therapies-for-ms-120115-4486686/ 2015-01-12T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/x-chem-janssen-to-advance-new-candidates-to-treat-inflammatory-diseases-120115-4486700/ 2015-01-12T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-isis-form-new-agreement-in-rna-therapeutics-120115-4486703/ 2015-01-12T05:18:00+00:00 https://www.pharmaceutical-business-review.com/news/ligand-partner-retrophin-receives-orphan-drug-designation-for-sparsentan-120115-4486693/ 2015-01-12T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-for-scynexis-scy-078-to-treat-invasive-fungal-infections-120115-4487063/ 2015-01-12T08:02:00+00:00 https://www.pharmaceutical-business-review.com/news/cipher-takes-over-assets-of-melanovus-oncology-120115-4487088/ 2015-01-12T08:06:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-invests-103bn-to-buy-majority-stake-in-foundation-medicine-130115-4487395/ 2015-01-13T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/adimab-gsk-expand-collaboration-for-new-bispecific-antibodies-130115-4487492/ 2015-01-13T03:21:00+00:00 https://www.pharmaceutical-business-review.com/news/medimmune-omnis-pharmaceuticals-enter-cancer-immunotherapy-deal-130115-4487659/ 2015-01-13T03:22:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-accepts-to-review-regeneron-and-sanofis-maa-for-hypercholesterolemia-drug-praluent-130115-4487733/ 2015-01-13T03:26:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-inks-deal-with-ferrara-to-enter-gummy-vitamins-and-dietary-supplement-market-130115-4487676/ 2015-01-13T03:27:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-secures-fda-approval-for-long-acting-parkinsons-treatment-duopa-130115-4488133/ 2015-01-13T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-md-anderson-enter-research-agreement-to-develop-bite-therapies-for-myelodysplastic-syndrome-130115-4488145/ 2015-01-13T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/biomarin-reports-positive-preliminary-data-from-phase-iii-trial-of-bmn-190-130115-4488159/ 2015-01-13T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/axxess-pharma-gets-approval-to-sell-tapout-products-to-more-than-2000-independent-pharmacies-130115-4488181/ 2015-01-13T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/elite-one-acquires-nutritional-labs-international-130115-4488191/ 2015-01-13T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/mundipharma-purdue-and-esteve-partner-for-new-pain-management-medicines-130115-4487919/ 2015-01-13T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/prasco-takeda-partner-to-market-authorized-generic-of-colcrys-tablets-in-us-130115-4487772/ 2015-01-13T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-enters-into-antibiotic-license-deal-with-meiji-and-fedora-140115-4488596/ 2015-01-14T00:17:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-to-sell-otc-business-to-gsk-consumer-for-176m-140115-4488641/ 2015-01-14T03:14:00+00:00 https://www.pharmaceutical-business-review.com/news/psioxus-gets-positive-opinion-from-ema-committee-for-ovarian-cancer-oncolytic-vaccine-140115-4488839/ 2015-01-14T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-lilly-to-research-immuno-oncology-combination-regimens-140115-4488801/ 2015-01-14T03:26:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-yale-university-to-research-new-immunotherapy-targets-140115-4488890/ 2015-01-14T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-vedanta-enter-license-deal-for-lead-microbiome-pharmaceutical-candidate-140115-4488996/ 2015-01-14T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/bellicum-completes-dosing-in-first-patient-cohort-with-bpx-501-t-cells-in-phase-iii-trial-140115-4489026/ 2015-01-14T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/kalgene-signs-license-deal-with-nrc-to-develop-new-alzheimers-therapeutics-140115-4489238/ 2015-01-14T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/delmar-gets-notice-of-allowance-for-third-us-patent-for-val-083-140115-4489242/ 2015-01-14T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-introduces-us-generic-specialty-injectable-portfolio-140115-4489248/ 2015-01-14T06:45:00+00:00 https://www.pharmaceutical-business-review.com/news/allegro-hanmi-to-develop-and-market-luminate-in-korea-and-china-140115-4489256/ 2015-01-14T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/celsus-closes-patient-enrollment-in-phase-ii-trial-of-mrx-6-cream-2-in-pediatric-atopic-dermatitis-140115-4489261/ 2015-01-14T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/vical-anges-partner-for-equine-polyclonal-antibody-therapy-against-ebola-150115-4489361/ 2015-01-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/all-wales-medicines-strategy-group-recommends-gsks-copd-drug-incruse-150115-4489363/ 2015-01-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-moderna-to-develop-mrna-based-antiviral-vaccines-and-passive-immunity-therapies-150115-4489365/ 2015-01-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-reports-data-from-phase-ii-peak-and-phase-iii-prime-trials-of-vectibix-and-folfox-combination-150115-4490402/ 2015-01-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-reports-pegasus-timi-54-trial-meets-primary-endpoint-150115-4490418/ 2015-01-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-vanderbilt-university-to-develop-new-ras-inhibitors-to-treat-cancer-150115-4490421/ 2015-01-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/3sbio-inks-patent-license-deal-with-pharmabcine-for-dig-kt-150115-4490429/ 2015-01-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/akorn-confirms-generic-durezol-patent-challenge-150115-4490434/ 2015-01-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aegerion-completes-acquisition-of-myalept-from-astrazeneca-150115-4489359/ 2015-01-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/depomed-agrees-to-buy-janssens-nucynta-us-license-for-105bn-160115-4489787/ 2015-01-15T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/biocrysts-bcx4161-gets-positive-opinion-on-european-orphan-drug-designation-for-hae-160115-4489926/ 2015-01-16T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-lamivudine-tablets-100mg-to-treat-hepatitis-b-virus-160115-4490048/ 2015-01-16T03:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-for-pernix-treximet-snda-to-treat-migraine-in-adolescent-patients-160115-4490020/ 2015-01-16T03:05:00+00:00 https://www.pharmaceutical-business-review.com/news/tonix-begins-dosing-in-phase-ii-trial-of-tnx-102-sl-to-treat-post-traumatic-stress-disorder-160115-4490064/ 2015-01-16T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/celtic-biotech-iowa-secures-patent-from-us-patent-and-trademark-office-160115-4490438/ 2015-01-16T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/ocusoft-launches-hypochlor-spray-and-gel-160115-4490472/ 2015-01-16T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/wcct-global-collaborates-with-niaid-for-influenza-challenge-research-160115-4490481/ 2015-01-16T06:25:00+00:00 https://www.pharmaceutical-business-review.com/news/dose-of-nature-launches-new-cbd-product-line-160115-4490492/ 2015-01-16T06:29:00+00:00 https://www.pharmaceutical-business-review.com/news/stevia-submits-provisional-patent-application-to-uspto-for-cbd-and-acetaminophen-formulation-to-treat-pain-160115-4490493/ 2015-01-16T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-sanofi-partner-to-produce-monoclonal-antibodies-160115-4490163/ 2015-01-16T07:27:00+00:00 https://www.pharmaceutical-business-review.com/news/oncomed-starts-phase-ia-trial-of-omp-52m51-to-treat-solid-tumors-160115-4490109/ 2015-01-16T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/dramatic-shifts-in-pharma-drive-patient-needs-to-trump-all-including-c-suite-authority-190115-4489370/ 2015-01-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genspera-reports-positive-results-from-phase-ii-trial-of-mipsagargin-to-treat-hcc-190115-4491557/ 2015-01-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/johnson-gets-100m-from-europes-imi-to-accelerate-ebola-vaccine-development-190115-4490771/ 2015-01-19T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-neurocrines-nbi-77860-to-treat-cah190115-4490889/ 2015-01-19T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-secures-european-approval-to-market-viekirax-exviera-to-treat-hcv-190115-4490923/ 2015-01-19T02:10:00+00:00 https://www.pharmaceutical-business-review.com/news/piramal-to-acquire-coldstream-laboratories-for-3065m-190115-4490975/ 2015-01-19T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/antibe-suspends-phase-i-trial-of-atb-346-due-to-safety-concerns-190115-4491002/ 2015-01-19T03:32:00+00:00 https://www.pharmaceutical-business-review.com/news/neuropore-ucb-partner-to-develop-new-treatment-for-parkinsons-disease-190115-4491027/ 2015-01-19T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-grants-marketing-authorisation-for-celgenes-otezla-to-treat-psoriasis-and-psoriatic-arthritis-190115-4491461/ 2015-01-19T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/oramed-granted-patent-in-israel-for-oral-administration-of-glp-1-190115-4491469/ 2015-01-19T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/caris-molecular-intelligence-identifies-therapeutic-options-for-patients-with-ascc-190115-4491476/ 2015-01-19T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/vicus-reports-safety-and-survival-benefit-of-vt-122-in-combination-with-anti-cancer-therapies-190115-4491465/ 2015-01-19T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/abattis-enters-into-manufacturing-partnership-with-empirical-labs-190115-4491480/ 2015-01-19T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-novartis-psoriasis-drug-cosentyx-200115-4491688/ 2015-01-19T23:59:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-enters-into-research-collaboration-with-c4x-discovery-200115-4491993/ 2015-01-20T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringers-nintedanib-gets-european-approval-to-treat-idiopathic-pulmonary-fibrosis-200115-4491936/ 2015-01-20T03:20:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-for-janssens-schizophrenia-treatment-200115-4492056/ 2015-01-20T03:21:00+00:00 https://www.pharmaceutical-business-review.com/news/oncore-agrees-to-merge-with-tekmira-to-develop-nvp018-for-hepatitis-b-treatment-200115-4492241/ 2015-01-20T03:24:00+00:00 https://www.pharmaceutical-business-review.com/news/addex-dmrf-partner-to-explore-therapeutic-use-of-dipraglurant-in-dystonia-treatment-200115-4492250/ 2015-01-20T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/amri-gets-nih-contract-for-drug-development-and-manufacturing-services-020115-4492260/ 2015-01-20T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-joins-precompetitive-research-consortium-to-accelerate-drug-discovery-200115-4492627/ 2015-01-20T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/solasia-meiji-seika-pharma-enter-into-license-agreement-for-darinaparsin-200115-4492634/ 2015-01-20T06:26:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-fresenius-neostigmine-methylsulfate-injection-200115-4492163/ 2015-01-20T07:31:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-launches-xultophy-in-switzerland-to-treat-type-2-diabetes-200115-4492223/ 2015-01-20T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/marathons-deflazacort-gets-fda-fast-track-status-to-treat-duchenne-muscular-dystrophy-200115-4492123/ 2015-01-20T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-baxters-phoxillum-renal-replacement-solution-210115-4493010/ 2015-01-21T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/visivite-reports-launch-of-provision-macular-health-formula-210115-4493088/ 2015-01-21T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/dynport-vaccine-lands-90m-follow-on-clinical-trials-contract-with-niaid-210115-4493163/ 2015-01-21T03:11:00+00:00 https://www.pharmaceutical-business-review.com/news/enzymotec-begins-24-month-clinical-trial-of-vayacog-in-mci-patients-210115-4493304/ 2015-01-21T03:22:00+00:00 https://www.pharmaceutical-business-review.com/news/spark-begins-phase-iii-trial-of-spk-chm-to-treat-choroideremia-210115-4493383/ 2015-01-21T03:22:00+00:00 https://www.pharmaceutical-business-review.com/news/verastem-gets-european-orphan-medicinal-product-status-for-vs-5584-in-mesothelioma-210115-4493336/ 2015-01-21T03:24:00+00:00 https://www.pharmaceutical-business-review.com/news/tobira-begins-dosing-in-phase-i-trial-of-cenicriviroc-and-pioglitazone-210115-4493424/ 2015-01-21T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-innovation-center-opens-at-the-university-of-illinois-urbana-research-park-210115-4493978/ 2015-01-21T08:16:00+00:00 https://www.pharmaceutical-business-review.com/news/european-label-update-of-bayers-xarelto-now-including-guidance-for-use-in-af-patients-undergoing-cardioversion-210115-4493984/ 2015-01-21T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/immunomedics-reports-phase-iii-results-of-sacituzumab-govitecan-in-gastrointestinal-cancers-patients-210115-4493983/ 2015-01-21T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/critical-outcome-technologies-planning-phase-i-trial-of-coti-2-in-recurrent-head-and-neck-cancers-210115-4493981/ 2015-01-21T08:23:00+00:00 https://www.pharmaceutical-business-review.com/news/am-pharma-initiates-phase-ii-trial-of-recap-in-aki-patients-220115-4493878/ 2015-01-22T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-novartis-cosentyx-to-treat-plaque-psoriasis-220115-4494191/ 2015-01-22T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-launches-spiriva-respimat-in-us-220115-4494359/ 2015-01-22T03:37:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-for-celators-leukemia-drug-cpx-351-220115-4494456/ 2015-01-22T03:39:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmalinks-ind-application-for-iga-nephropathy-now-open-with-fda-220115-4494498/ 2015-01-22T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/ocular-begins-patient-enrolment-in-dexamethasone-phase-ii-trial-for-dry-eye-disease-220115-4494468/ 2015-01-22T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/curis-aurigene-partner-to-develop-precision-oncology-targets-220115-4495053/ 2015-01-22T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/minerva-neurosciences-reports-positive-phase-i-data-with-min-202-220115-4495064/ 2015-01-22T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-announces-us-and-eu-regulatory-filings-for-brivaracetam-220115-4495071/ 2015-01-22T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/kinex-doses-first-patient-with-kx2-391-ointment-for-actinic-keratosis-in-phase-i-trial-220115-4495080/ 2015-01-22T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/trovagene-expands-clinical-collaboration-with-genomac-220115-4495077/ 2015-01-22T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/oncosynergys-cancer-drug-os2966-gets-fda-orphan-drug-status-220115-4494437/ 2015-01-22T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/kineta-closes-patient-enrollment-in-phase-ib-trial-of-shk-186-to-treat-psoriasis-230114-4495011/ 2015-01-23T00:07:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-accepts-astrazenecas-maa-for-gout-treatment-lesinurad-230115-4495355/ 2015-01-23T00:24:00+00:00 https://www.pharmaceutical-business-review.com/news/genzymes-cerdelga-gets-european-marketing-authorization-for-gaucher-disease-230115-4495502/ 2015-01-23T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-committee-recommends-approval-of-astellas-cresemba-230115-4495618/ 2015-01-23T07:09:00+00:00 https://www.pharmaceutical-business-review.com/news/novamedica-gets-russian-rights-for-three-gastrointestinal-products-from-omega-pharma-230115-4495679/ 2015-01-23T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/apreas-ovarian-cancer-drug-candidate-apr-246-gets-european-orphan-drug-status-230115-4495553/ 2015-01-23T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-advaxis-ind-application-to-conduct-phase-i-trial-of-adxs-her2-230115-4495577/ 2015-01-23T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-prevenar-13-gets-chmp-positive-opinion-for-prevention-of-vaccine-type-pneumococcal-pneumonia-in-adults-230115-4496144/ 2015-01-23T08:46:00+00:00 https://www.pharmaceutical-business-review.com/news/syncona-uclb-form-cancer-immunotherapy-firm-autolus-230115-4496139/ 2015-01-23T08:48:00+00:00 https://www.pharmaceutical-business-review.com/news/wcct-global-enters-into-clinical-research-partnerhip-with-dynport-vaccine-company-230115-4496150/ 2015-01-23T08:50:00+00:00 https://www.pharmaceutical-business-review.com/news/tigenix-gets-european-patent-relating-to-adipose-derived-stem-cell-composition-230115-4496154/ 2015-01-23T08:52:00+00:00 https://www.pharmaceutical-business-review.com/news/cytrx-reports-overall-survival-results-from-phase-iib-trial-of-aldoxorubicin-230115-4496146/ 2015-01-23T08:54:00+00:00 https://www.pharmaceutical-business-review.com/news/alexza-begins-phase-iia-trial-of-az-002-to-treat-epilepsy-patients-260115-4495793/ 2015-01-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/immupharma-simbec-orion-collaborate-to-execute-phase-iii-lupuzor-trial-for-lupus-260115-4496184/ 2015-01-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biocryst-gets-fda-fast-track-status-for-bcx4161-to-treat-hereditary-angioedema-260115-4497067/ 2015-01-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bayers-aflibercept-solution-for-injection-gets-recommendation-for-approval-in-eu-260115-4497077/ 2015-01-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-bexsero-vaccine-gets-fda-approval-for-prevention-of-meningitis-b-260115-4497116/ 2015-01-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-jakavi-recommended-by-chmp-for-eu-approval-to-treat-polycythemia-vera-260115-4497123/ 2015-01-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-natpara-for-injection-to-control-hypocalcemia-in-patients-with-hypoparathyroidism-260115-4497126/ 2015-01-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ema-recommends-suspension-of-sale-medicines-based-on-gvk-bios-flawed-clinical-data-4496354/ 2015-01-26T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/scientist-finds-way-to-improve-antibiotics-to-treat-staph-infections-4496388/ 2015-01-26T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-symplmeds-hypertension-drug-prestalia-270115-4497537/ 2015-01-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-for-priority-review-sanofi-and-regenerons-bla-for-hypercholesterolemia-drug-praluent-270115-4496641/ 2015-01-27T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-issues-positive-opinion-for-mercks-sivextro-to-treat-absssi-270115-4496757/ 2015-01-27T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/opsona-starts-opn-305-phase-iii-trial-to-treat-myelodysplastic-syndrome-270115-4496990/ 2015-01-27T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/cel-sci-secures-approval-in-romania-to-start-phase-iii-multikine-trial-270115-4497064/ 2015-01-27T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/enlivex-secures-eu-orphan-drug-status-for-apocell-to-treat-gvhd-270115-4497113/ 2015-01-27T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/synageva-starts-dosing-in-phase-iii-trial-of-sbc-103-to-treat-mps-iiib-270115-4497171/ 2015-01-27T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-ajinomoto-launch-livamin-oral-granules-in-philippines-270115-4497531/ 2015-01-27T08:06:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-expands-hepatitis-c-generic-licensing-agreements-to-include-investigational-ns5a-inhibitor-gs-5816-270115-4497532/ 2015-01-27T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/plandai-secures-collaboration-agreement-to-further-cannabis-research-in-uruguay-270115-4497534/ 2015-01-27T08:14:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-to-buy-auden-mckenzie-for-gbp306m-270115-4497536/ 2015-01-27T08:18:00+00:00 https://www.pharmaceutical-business-review.com/news/bosch-expands-cps-portfolio-for-serialization-of-pharmaceutical-packaging-270115-4497499/ 2015-01-27T08:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-pay-400m-to-end-shareholder-suit-over-off-label-marketing-280115-4498646/ 2015-01-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-phri-and-c-spin-to-conduct-phase-iii-trial-of-rivaroxaban-to-treat-esus-patients-280115-4497733/ 2015-01-28T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/moberg-pharma-gets-chinese-approval-for-kerasal-nail-280115-4498096/ 2015-01-28T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/some-otc-drugs-linked-to-increased-chance-of-dementia-study-280115-4498017/ 2015-01-28T03:39:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-seeks-approval-for-myeloma-drug-kyprolis-in-us-and-europe-280115-4498124/ 2015-01-28T03:39:00+00:00 https://www.pharmaceutical-business-review.com/news/vifor-pharma-hyperphosphatemia-drug-velphoro-gets-swissmedic-approval-280115-4498184/ 2015-01-28T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/apricus-biosciences-announces-issuance-of-us-patent-for-rayva-280115-4498093/ 2015-01-28T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/wcct-global-to-collaborate-with-dr-garry-nolans-laboratory-to-explore-systems-level-host-responses-to-influenza-280115-4498098/ 2015-01-28T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/annette-funicello-funds-promising-neurovascular-research-280115-4498103/ 2015-01-28T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/council-for-responsible-nutrition-releases-guidelines-on-iodine-in-multivitaminmineral-supplements-for-pregnancy-and-lactation-280115-4498110/ 2015-01-28T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-launches-fomepizole-intravenous-infusion-15g-in-japan-280115-4498115/ 2015-01-28T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/envisia-begins-phase-iia-trial-of-env515-to-treat-glaucoma-patients-280115-4498262/ 2015-01-28T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/macrogenics-janssen-end-license-deal-for-mgd011-to-treat-multiple-b-cell-malignancies-280115-4498667/ 2015-01-28T08:01:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-reports-positive-results-from-jakavi-phase-iii-trial-in-patients-with-polycythemia-vera-290115-4498979/ 2015-01-29T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-medicinovas-ind-for-mn-001-to-treat-nash-290115-4499315/ 2015-01-29T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/galmed-and-perrigo-in-manufacturing-services-agreement-for-aramchol-api-production-290115-4499205/ 2015-01-29T03:11:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-gsk-and-novartis-three-part-transaction-290115-4499103/ 2015-01-29T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-restorgenex-res-529-to-treat-glioblastoma-multiforme-290115-4499282/ 2015-01-29T03:26:00+00:00 https://www.pharmaceutical-business-review.com/news/regenerx-g-treebnt-form-joint-venture-to-develop-rgn-259-in-us-290115-4499260/ 2015-01-29T03:39:00+00:00 https://www.pharmaceutical-business-review.com/news/goodwin-transporin-enter-technology-collaboration-to-improve-ability-of-antibody-drug-conjugates-290115-4499271/ 2015-01-29T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/adamis-receives-notice-of-allowance-for-us-and-japanese-patents-for-dry-powder-inhaler-taper-dpi-290115-4499278/ 2015-01-29T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/agenebio-secures-addf-grant-for-new-approach-to-delaying-onset-of-alzheimers-dementia-290115-4499287/ 2015-01-29T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/sumitomo-chemical-develops-sumilarv-2-mr-to-prevent-dengue-fever-290115-4499293/ 2015-01-29T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/sorrento-completes-patient-enrollment-in-cynviloq-tribeca-registrational-trial-290115-4499394/ 2015-01-29T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/applied-molecular-transport-janssen-enter-research-and-license-deal-for-ibs-therapy-290115-4499349/ 2015-01-29T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-evotaz-gets-fda-approval-for-hiv-1-treatment-in-adults-300115-4500076/ 2015-01-30T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-pharmacyclics-and-janssen-imbruvica-to-treat-waldenstroms-macroglobulinemia-300115-4500354/ 2015-01-30T03:14:00+00:00 https://www.pharmaceutical-business-review.com/news/oncomeds-cancer-drug-tarextumab-gets-fda-orphan-drug-status-300115-4500384/ 2015-01-30T03:14:00+00:00 https://www.pharmaceutical-business-review.com/news/international-stem-cell-to-begin-phase-iiia-parkinsons-disease-trial-in-australia-300115-4500405/ 2015-01-30T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/endo-completes-26bn-acquisition-of-auxilium-300115-4500313/ 2015-01-30T03:16:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-to-develop-immunomics-jrc2-lamp-vax-to-treat-japanese-red-cedar-pollinosis-300115-4500456/ 2015-01-30T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/medicinova-gets-new-patent-covering-mn-029-denibulin-di-hydrochloride-in-japan-300115-4500854/ 2015-01-30T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/intercept-gets-fda-breakthrough-therapy-status-for-obeticholic-acid-to-treat-nash-with-liver-fibrosis-300115-4500861/ 2015-01-30T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/janssens-prezcobix-gets-fda-approval-to-treat-adults-living-with-hiv-1-300115-4500867/ 2015-01-30T07:01:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-patent-for-vg-life-sciences-covering-treatment-of-ibd-with-clip-inducing-agent-300115-4500874/ 2015-01-30T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/reata-enrolls-first-patient-in-phase-iiiii-moxie-study-of-rta-408-in-friedreichs-ataxia-patients-300115-4500885/ 2015-01-30T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-to-use-crispr-genome-editing-technology-for-key-therapeutic-areas-300115-4500904/ 2015-01-30T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-shires-vyvanse-to-treat-adults-with-binge-eating-disorder-020215-4501194/ 2015-02-02T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/chimerix-stops-participation-in-brincidofovir-ebola-trials-020215-4501383/ 2015-02-02T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/ani-pharmaceuticals-introduces-etodolac-300mg-oral-capsules-020215-4501470/ 2015-02-02T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-stemlines-glioma-treatment-sl-701-020215-4501500/ 2015-02-02T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-zogenixs-new-formulation-of-zohydro-er-020215-4501530/ 2015-02-02T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/rock-creek-gets-uk-mhra-nod-to-begin-phase-i-trial-of-anatabine-citrate-020215-4501627/ 2015-02-02T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-reports-top-line-results-from-phase-iii-trial-of-all-oral-hepatitis-c-treatment-in-japan-020215-4501928/ 2015-02-02T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/vital-therapies-reports-phase-iii-trial-of-vti-208-reaches-enrollment-target-020215-4501933/ 2015-02-02T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/serendex-cmc-biologics-enter-exclusive-agreement-on-factor-viia-020215-4501939/ 2015-02-02T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/matinas-biopharma-acquires-aquarius-biotechnologies-020215-4501944/ 2015-02-02T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/novadel-pharma-sells-remaining-assets-of-zolpimist-nda-to-amherst-for-22m-020215-4501949/ 2015-02-02T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/opko-seeks-fda-approval-to-begin-phase-iia-trial-of-factor-viia-ctp-to-treat-hemophilia-020215-4501915/ 2015-02-02T08:44:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-and-lillys-type-2-diabetes-combination-drug-glyxambi-gets-fda-approval-030215-4502190/ 2015-02-03T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/roches-nsclc-therapy-mpdl3280a-gets-fda-breakthrough-therapy-status-030215-4502262/ 2015-02-03T03:08:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-alcons-pazeo-solution-for-ocular-allergy-itch-relief-030215-4502722/ 2015-02-03T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/viking-enters-research-deal-with-amc-for-new-thyroid-beta-agonists-to-treat-x-ald-030215-4502603/ 2015-02-03T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/intellipharmaceutics-teva-partner-for-extended-release-oral-drug-product-candidate-030215-4502780/ 2015-02-03T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/theravance-mylan-to-develop-and-commercialize-new-lama-compound-to-treat-copd-030215-4502831/ 2015-02-03T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmacyte-begins-first-preclinical-study-of-encapsulated-cell-product-for-new-diabetes-treatment-030215-4503058/ 2015-02-03T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-new-dosing-option-for-csl-behrings-hizentra-030215-4503054/ 2015-02-03T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/insite-vision-enters-into-license-agreement-with-nicox-for-azasite-azasite-xtra-and-bromsite-in-emea-030215-4503066/ 2015-02-03T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-discontinues-phase-ii-program-for-dtapsipv-vaccine-in-japan-030215-4503071/ 2015-02-03T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/helsinn-grants-stendhal-exclusive-rights-to-distribute-and-markete-nepa-030215-4503079/ 2015-02-03T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/lpath-seeks-fda-approval-to-begin-phase-i-trial-of-pain-drug-lpathomab-030215-4503104/ 2015-02-03T08:11:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-mannkind-launch-diabetes-drug-afrezza-in-us-040215-4503424/ 2015-02-04T00:15:00+00:00 https://www.pharmaceutical-business-review.com/news/arenas-weight-management-drug-belviq-gets-marketing-approval-in-south-korea-040215-4503696/ 2015-02-04T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-launches-insomnia-drug-belsomra-in-us-040215-4503819/ 2015-02-04T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-accelerated-approval-for-pfizers-breast-cancer-drug-ibrance-040215-4503887/ 2015-02-04T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/elysium-health-introduces-basis-to-improve-metabolic-repair-and-optimization-040215-4503727/ 2015-02-04T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/moderna-institut-pasteur-enter-research-collaboration-for-new-mrna-vaccines-040215-4503763/ 2015-02-04T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/inergetics-completes-final-launch-preparations-for-new-cbd-based-pain-relief-supplement-040215-4503981/ 2015-02-04T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/international-stem-cell-completes-cell-bank-manufacturing-for-parkinsons-disease-clinical-trial-040215-4503991/ 2015-02-04T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/aurinia-gets-japanese-and-chinese-patents-for-nanomicellar-formulation-of-voclosporin-040215-4504208/ 2015-02-04T06:38:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-for-pharmamars-yondelis-nda-040215-4504190/ 2015-02-04T06:41:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-agrees-to-buy-famy-care-businesses-040215-4504212/ 2015-02-04T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/ligand-sermonix-ink-license-deal-for-lasofoxifene-040215-4504217/ 2015-02-04T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-pfizers-snda-for-plaque-psoriasis-drug-xeljanz-050215-4504518/ 2015-02-05T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-reports-positive-phase-iii-trial-results-of-lymphoma-drug-gazyva-050215-4504783/ 2015-02-05T03:11:00+00:00 https://www.pharmaceutical-business-review.com/news/kythera-seeks-approval-in-australia-for-submental-contouring-injectable-drug-atx-101-050215-4504810/ 2015-02-05T03:11:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-actavis-snda-to-expand-teflaro-labeling-for-absssi-with-concurrent-bacteremia-050215-4504900/ 2015-02-05T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-gets-vimovo-related-patent-with-protection-to-2031-from-uspto-050215-4505392/ 2015-02-05T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/rich-pharmaceuticals-completes-manufacturing-of-rp-323-study-drug-050215-4505396/ 2015-02-05T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/mast-therapeutics-begins-phase-iia-studies-of-air001-in-patients-with-hfpef-050215-4505399/ 2015-02-05T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmacyte-begins-development-of-diabetes-treatment-with-first-preclinical-study-050215-4505403/ 2015-02-05T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-enrolls-first-patients-in-phase-iii-clinical-programs-for-mirogabalin-050215-4505407/ 2015-02-05T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/oncomed-begins-patient-dosing-in-phase-ii-trial-of-lung-cancer-drug-demcizumab-050215-4505306/ 2015-02-05T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-sangamos-ind-to-begin-clinical-trial-of-new-zfp-therapeutic-for-beta-thalassemia-050215-4505390/ 2015-02-05T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/qr-pharma-rockefeller-university-enter-research-deal-for-posiphen-to-treat-huntingtons-disease-050215-4505349/ 2015-02-05T13:32:00+00:00 https://www.pharmaceutical-business-review.com/news/mp-global-products-introduces-foam-free-packaging-for-shipment-of-temperature-sensitive-pharmaceuticals-060215-4505744/ 2015-02-06T00:33:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-agrees-to-buy-hospira-for-17bn-060215-4505718/ 2015-02-06T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-agrees-to-acquire-rights-to-actavis-lung-drugs-for-600m-060215-4505856/ 2015-02-06T03:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nutra-pharma-announces-distribution-of-otc-pain-drug-nyloxin-to-india-060215-4506538/ 2015-02-06T07:48:00+00:00 https://www.pharmaceutical-business-review.com/news/akaal-pharma-reports-positive-phase-i-results-of-psoriasis-drug-candidate-akp-11-060215-4506476/ 2015-02-06T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/ppf-group-acquires-minority-stake-in-cytune-pharma-060215-4506503/ 2015-02-06T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/ferring-launches-nocdurna-in-canada-for-adults-suffering-from-nocturia-060215-4506373/ 2015-02-06T07:52:00+00:00 https://www.pharmaceutical-business-review.com/news/rxi-pharma-closes-licensing-deal-with-hapten-for-samcyprone-060215-4506526/ 2015-02-06T07:54:00+00:00 https://www.pharmaceutical-business-review.com/news/ignyta-gets-fda-orphan-drug-status-for-lung-cancer-drug-entrectinib-060215-4506397/ 2015-02-06T07:55:00+00:00 https://www.pharmaceutical-business-review.com/news/helsinn-begins-phase-iib-clinical-dose-finding-trial-of-elsiglutide-060215-4506546/ 2015-02-06T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/bpi-sports-adopts-chromadex-quality-verification-seal-program-060215-4506548/ 2015-02-06T08:01:00+00:00 https://www.pharmaceutical-business-review.com/news/neuronascent-announces-expanded-patent-coverage-in-us-and-russia-for-nni-362-060215-4506551/ 2015-02-06T08:05:00+00:00 https://www.pharmaceutical-business-review.com/news/juno-therapeutics-enters-into-lease-agreement-for-manufacturing-facility-in-washington-090215-4508759/ 2015-02-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/janssens-velcade-gets-european-approval-to-treat-mantle-cell-lymphoma-090215-4506780/ 2015-02-09T00:15:00+00:00 https://www.pharmaceutical-business-review.com/news/adimab-sanofi-enter-new-bispecific-antibody-collaboration-090215-4507086/ 2015-02-09T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-seeks-ema-approval-for-additional-indication-of-eltrombopag-to-treat-itp-090215-4507033/ 2015-02-09T03:42:00+00:00 https://www.pharmaceutical-business-review.com/news/genentechs-lucentis-gets-fda-approval-to-treat-diabetic-retinopathy-in-dme-patients-090215-4507152/ 2015-02-09T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-committee-to-review-theravances-breo-ellipta-ffvi-for-asthma-090215-4507615/ 2015-02-09T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cochrane-confirms-clinical-efficacy-of-chondroitin-sulfate-to-treat-osteoarthritis-090215-4507607/ 2015-02-09T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/dermira-announces-positive-phase-iib-results-for-drm04-in-hyperhidrosis-patients-090215-4507613/ 2015-02-09T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/vbl-therapeutics-gets-european-patent-on-lecinoxoid-technology-090215-4507187/ 2015-02-09T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/crystalgenomics-osteoarthritis-drug-acelex-gets-approval-in-south-korea-090215-4507268/ 2015-02-09T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/enwave-announces-new-significant-patent-approval-090215-4507602/ 2015-02-09T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/adocia-reports-positive-phase-iia-trial-results-of-hinsbet-in-type-1-diabetes-patients-090215-4507633/ 2015-02-09T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-theravance-begin-phase-iii-lung-cancer-trial-with-triple-combination-therapy-100215-4507941/ 2015-02-10T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/bio-path-begins-patient-enrollment-in-phase-ii-trial-of-leukemia-drug-liposomal-grb-2-100215-4508164/ 2015-02-10T03:11:00+00:00 https://www.pharmaceutical-business-review.com/news/aurinia-to-start-open-label-trial-to-evaluate-impact-of-voclosporin-in-lupus-nephritis-100215-4508188/ 2015-02-10T03:12:00+00:00 https://www.pharmaceutical-business-review.com/news/biotest-opens-second-jacksonville-plasma-center-100215-4508283/ 2015-02-10T03:14:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-for-filing-inspirion-deliverys-morphabond-er-nda-100215-4508240/ 2015-02-10T03:17:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-to-divest-us-rights-of-doryx-to-mayne-pharma-for-50m-100215-4508310/ 2015-02-10T04:09:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-aits-high-dose-nitric-oxide-formulation-to-treat-cf-100215-4508353/ 2015-02-10T04:11:00+00:00 https://www.pharmaceutical-business-review.com/news/biopharma-enters-into-strategic-partnership-agreement-with-scentryphar-100215-4508772/ 2015-02-10T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/vaxxas-secures-equity-funding-of-20m-to-accelerate-commercialization-of-new-vaccine-platform-100215-4508792/ 2015-02-10T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/lyceras-research-shows-promising-anti-cancer-activity-of-new-oral-immunotherapy-candidates-100215-4508803/ 2015-02-10T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/adamas-reports-results-from-phase-iiiii-clinical-trial-of-ads-5102-100215-4508808/ 2015-02-10T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/aduro-biotech-achieves-first-development-milestone-under-collaboration-with-janssen-100215-4508810/ 2015-02-10T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-vtu-technology-renew-deal-for-new-therapeutic-proteins-110215-4508912/ 2015-02-11T00:10:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-karolinska-institutet-partner-for-diabetes-research-program-110215-4509257/ 2015-02-11T02:51:00+00:00 https://www.pharmaceutical-business-review.com/news/moberg-pharma-berlin-chemie-extend-distribution-deal-for-emtrix-11215-4509294/ 2015-02-11T03:01:00+00:00 https://www.pharmaceutical-business-review.com/news/pfenex-hospira-to-develop-and-commercialize-proposed-biosimilar-of-lucentis-110215-4509328/ 2015-02-11T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/julphar-acquires-majority-stake-in-rak-pharmaceuticals-for-95m-110215-4509461/ 2015-02-11T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/enteris-launches-contract-manufacturing-within-32000ft-fda-inspected-and-cgmp-compliant-facility-110215-4509465/ 2015-02-11T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/inoviem-scientific-raises-566000-in-seed-funding-from-cap-innovest-110215-4509762/ 2015-02-11T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmacytes-international-diabetes-consortium-sets-path-forward-to-develop-new-diabetes-treatment-110215-4509469/ 2015-02-11T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/synthetic-biologics-reports-positive-topline-phase-ib-results-of-syn-004-110215-4509476/ 2015-02-11T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/lion-gets-exclusive-license-from-nih-to-develop-til-therapy-for-metastatic-melanoma-110215-4509398/ 2015-02-11T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/panacea-accelovance-team-up-to-develop-new-cancer-vaccine-110215-4509368/ 2015-02-11T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-targazymes-tz101-for-use-with-regulatory-t-cells-110215-4509353/ 2015-02-11T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-acquires-remaining-stake-in-glycovaxyn-for-190m-120215-4510001/ 2015-02-11T23:21:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-seeks-approval-in-japan-for-new-treatment-of-patients-with-chronic-hcv-infection-120215-4510323/ 2015-02-12T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/heron-begins-phase-i-trial-of-htx-011-to-treat-post-operative-pain-120215-4510350/ 2015-02-12T04:19:00+00:00 https://www.pharmaceutical-business-review.com/news/voyager-genzyme-to-develop-new-aav-gene-therapies-for-patients-with-cns-disorders-120215-4510238/ 2015-02-12T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-incyte-enter-clinical-trial-collaboration-for-cervical-cancer-drug-120215-4510482/ 2015-02-12T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/cel-sci-gets-clearance-in-philippines-to-begin-phase-iii-head-and-neck-cancer-trial-of-multikine-120215-4510510/ 2015-02-12T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/cumberland-begins-phase-ii-clinical-development-program-of-boxaban-to-treat-aerd-120215-4510398/ 2015-02-12T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-launches-new-research-platforms-focus-healthcare-4511647/ 2015-02-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-reports-positive-phase-iii-trial-results-of-type-1-gaucher-disease-drug-elelyso-130215-4511077/ 2015-02-13T00:05:00+00:00 https://www.pharmaceutical-business-review.com/news/aileron-starts-dosing-in-phase-i-cancer-trial-of-alrn-6924-130215-4511246/ 2015-02-13T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/affinivax-path-team-up-to-advance-vaccine-candidate-to-treat-pneumococcus-130215-4511360/ 2015-02-13T03:26:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-verastem-vs-5584-to-treat-mesothelioma-130215-4511382/ 2015-02-13T03:28:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-patent-relating-to-moberg-pharmas-mob-015-to-treat-onychomycosis-130215-4511517/ 2015-02-13T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-to-manufacture-cx601-product-for-tigenixs-phase-iii-trial-in-us-130215-4511460/ 2015-02-13T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-files-ind-application-for-actimmune-to-treat-friedreichs-ataxia-160215-4512856/ 2015-02-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-for-review-pfizers-nda-for-pain-drug-alo-02-160215-4512053/ 2015-02-16T00:09:00+00:00 https://www.pharmaceutical-business-review.com/news/moberg-pharma-introduces-kerasal-complete-care-in-us-160215-4512232/ 2015-02-16T02:19:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-gets-fda-priority-review-for-heart-failure-medicine-lcz696-160215-4512276/ 2015-02-16T02:59:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-gets-full-promotional-responsibility-for-erbitux-in-japan-160215-4512312/ 2015-02-16T03:47:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-eisais-thyroid-cancer-drug-lenvima-160215-4512377/ 2015-02-16T03:47:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-introduces-generic-version-of-astrazenecas-pulmicort-respules-160215-4512499/ 2015-02-16T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/zydus-completes-single-ascending-dose-phase-i-trial-of-anaemia-drug-zyan1-170215-4513195/ 2015-02-17T00:10:00+00:00 https://www.pharmaceutical-business-review.com/news/oncobiologics-ons-3010-meets-primary-endpoints-in-first-in-human-phase-i-trial-170215-4513452/ 2015-02-17T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/bexion-gets-fda-orphan-drug-status-for-saposin-c-to-treat-glioblastoma-multiforme-170215-4513481/ 2015-02-17T03:24:00+00:00 https://www.pharmaceutical-business-review.com/news/hospira-introduces-first-biosimilar-mab-inflectra-in-some-european-markets-170215-4513532/ 2015-02-17T04:19:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-expanded-approval-for-eisais-antiepileptic-drug-banzel-for-pediatric-patients-170215-4513602/ 2015-02-17T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/alzheimers-research-uk-launches-30m-dementia-drug-discovery-alliance-170215-4513388/ 2015-02-17T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-releases-positive-phase-i-trial-results-of-glpg1690-170215-4513934/ 2015-02-17T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-launches-generic-lovenox-and-zyvox-in-us-180215-4514204/ 2015-02-18T00:14:00+00:00 https://www.pharmaceutical-business-review.com/news/vistagen-nimh-partner-for-phase-ii-trial-of-av-101-to-treat-major-depressive-disorder-180215-4514365/ 2015-02-18T03:06:00+00:00 https://www.pharmaceutical-business-review.com/news/galderma-makes-soolantra-cream-1-available-in-us-for-rosacea-patients-180215-4514440/ 2015-02-18T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/medivector-completes-enrollment-in-two-phase-iii-trials-of-favipiravir-to-treat-influenza-180215-4514464/ 2015-02-18T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/adapt-pharma-gets-fda-fast-track-status-for-intranasal-naloxone-to-treat-opioid-overdose-180215-4514565/ 2015-02-18T04:07:00+00:00 https://www.pharmaceutical-business-review.com/news/agilvax-humabs-to-develop-targeted-vaccines-and-immunotherapies-180215-4514535/ 2015-02-18T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/lupin-celon-to-jointly-develop-generic-asthma-drug-180215-4514495/ 2015-02-18T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-lead-pharma-to-develop-new-autoimmune-treatments-190215-4515194/ 2015-02-19T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-to-commercialize-eagles-bendamustine-rapid-infusion-product-to-treat-cll-and-nhl-190215-4515501/ 2015-02-19T04:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-celgenes-revlimid-in-combination-with-dexamethasone-to-treat-multiple-myeloma-190215-4516045/ 2015-02-19T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/atyr-pharmas-resolaris-gets-ema-orphan-drug-status-for-fshd-190215-4516071/ 2015-02-19T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/ferring-buys-two-phase-iii-ready-orthobiologic-products-from-bioset-190215-4516083/ 2015-02-19T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-submits-supplemental-bla-to-fda-for-phase-iii-aethera-trial-of-adcetris-in-hl-patients-190215-4516104/ 2015-02-19T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/particle-sciences-produces-clinical-supplies-for-kinexs-kx2-361-to-treat-glioblastoma-190215-4516125/ 2015-02-19T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/targeted-medical-enters-into-distribution-agreement-with-j-network-in-japan-200215-4516455/ 2015-02-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-uks-qmul-partner-to-develop-new-therapies-for-gastrointestinal-diseases-200215-4516257/ 2015-02-20T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-bionovion-to-jointly-develop-immuno-oncology-targets-with-duobody-technology-200215-4516430/ 2015-02-20T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/kite-expands-manufacturing-capabilities-for-car-and-tcr-cancer-immunotherapy-products-200215-4516537/ 2015-02-20T02:45:00+00:00 https://www.pharmaceutical-business-review.com/news/valeo-pharma-enters-into-distribution-deal-with-questcor-for-synacthen-depot-in-canada-200215-4516509/ 2015-02-20T02:48:00+00:00 https://www.pharmaceutical-business-review.com/news/cel-sci-gets-malaysian-approval-to-initiate-phase-iii-trial-of-cancer-drug-multikine-200215-4516521/ 2015-02-20T02:49:00+00:00 https://www.pharmaceutical-business-review.com/news/genentechs-melanoma-drug-combination-gets-fda-priority-review-200215-4516556/ 2015-02-20T02:56:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-to-buy-salix-pharmaceuticals-for-145bn-4517295/ 2015-02-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/researchers-complete-gardasil-9-hpv-vaccines-international-phase-23-trial-230215-4517751/ 2015-02-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-secures-final-us-fda-approval-for-buprenorphine-sublingual-tablets-230215-4517782/ 2015-02-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sosei-acquires-biotechnology-company-heptares-therapeutics-for-400m-230215-4517633/ 2015-02-23T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-accepts-pfizers-snda-for-priority-review-of-rapamune-to-treat-lam-230215-4517747/ 2015-02-23T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/medimmune-nist-partner-to-advance-drug-discovery-and-manufacturing-230215-4517737/ 2015-02-23T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-agrees-to-ftcs-conditions-to-acquire-gsks-oncology-drugs-240215-4518277/ 2015-02-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/cyclenium-and-fundacin-medina-partner-to-discover-anti-infective-drug-candidates-240215-4518624/ 2015-02-24T03:56:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/rigel-bristol-myers-squibb-partner-to-develop-cancer-immunotherapies-240215-4518652/ 2015-02-24T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/ngm-merck-collaborate-to-develop-biologic-therapies-for-various-diseases-240215-4518706/ 2015-02-24T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/researchers-review-use-of-aspirin-for-cardiovascular-disease-prevention-240215-4519060/ 2015-02-24T08:30:00+00:00 https://www.pharmaceutical-business-review.com/news/indias-elder-pharma-expands-its-solo-range-of-otc-products-240215-4519061/ 2015-02-24T08:34:00+00:00 https://www.pharmaceutical-business-review.com/news/irelands-shire-buys-meritage-pharma-for-70m-250215-4519205/ 2015-02-25T01:02:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/merck-mpp-to-expand-access-to-pediatric-formulations-of-hiv-drug-raltegravir-250215-4519442/ 2015-02-25T03:17:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-phase-ii-trial-of-meningococcal-group-b-vaccine-meets-co-primary-immunogenicity-objectives-250215-4519459/ 2015-02-25T03:24:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-secures-option-to-buy-canbex-therapeutics-250215-4519397/ 2015-02-25T03:26:00+00:00 https://www.pharmaceutical-business-review.com/news/tevas-phase-iib-chronic-migraine-trial-of-tev-48125-meets-primary-secondary-endpoints-250215-4519508/ 2015-02-25T03:28:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-seeks-fda-approval-to-market-generic-ulcerative-colitis-drug-uceris-250215-4519536/ 2015-02-25T03:28:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-novartiss-multiple-myeloma-drug-farydak-250215-4519588/ 2015-02-25T03:32:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-orca-to-develop-new-drugs-for-autoimmune-diseases-260215-4520250/ 2015-02-25T23:47:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofis-diabetes-drug-toujeo-gets-fda-approval-260215-4520569/ 2015-02-26T03:21:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-for-review-tevas-nda-for-pain-management-tablets-260215-4520611/ 2015-02-26T03:28:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-actavis-antibacterial-drug-avycaz-to-treat-ciai-and-cuti-260215-4520497/ 2015-02-26T03:30:00+00:00 https://www.pharmaceutical-business-review.com/news/eisais-phase-iii-trial-of-sarcoma-drug-halaven-meets-primary-endpoint-260215-4520585/ 2015-02-26T03:31:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-two-patents-covering-ocatas-immune-modulatory-cell-technology-260215-4520690/ 2015-02-26T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-reports-positive-results-from-phase-iii-study-of-amg-416-with-cinacalcet-260215-4520890/ 2015-02-26T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/lupin-enters-into-clinical-research-partnership-with-acceliant-260215-4520764/ 2015-02-26T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/bayers-eylea-wins-approval-in-europe-to-treat-retinal-vein-occlusion-270215-4521463/ 2015-02-27T00:07:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-accepts-maa-for-amgens-myeloma-drug-kyprolis-270215-4521705/ 2015-02-27T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-grants-orphan-drug-status-for-toleros-leukemia-drug-alvocidib-270215-4521644/ 2015-02-27T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/portolas-factor-xa-inhibitor-antidote-andexanet-alfa-gets-fda-orphan-drug-status-270215-4521669/ 2015-02-27T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/obseva-releases-positive-results-from-phase-i-trial-of-obe001-to-treat-preterm-labour-270215-4521625/ 2015-02-27T03:39:00+00:00 https://www.pharmaceutical-business-review.com/news/columbia-to-begin-phase-ii-trial-of-lidocaine-bioadhesive-10-gel-270215-4521741/ 2015-02-27T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/triphase-sunnybrook-to-advance-development-new-bi-specific-antibody-for-cancer-patients-270215-4521768/ 2015-02-27T06:02:00+00:00 https://www.pharmaceutical-business-review.com/news/mundipharma-introduces-remsima-infliximab-in-six-european-countries-270215-4522172/ 2015-02-27T07:19:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-issues-positive-opinion-for-novartis-lung-cancer-drug-zykadia-020315-4522326/ 2015-03-02T00:07:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-gets-ema-positive-recommendation-for-avastin-plus-chemotherapy-to-treat-cervical-cancer-020315-4522614/ 2015-03-02T03:46:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-bristol-myers-bla-for-opdivo-to-treat-advanced-squamous-nsclc-020315-4522585/ 2015-03-02T03:47:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-and-medicines360-get-fda-approval-for-pregnancy-prevention-drug-liletta-020315-4522640/ 2015-03-02T03:49:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-acquires-non-us-specialty-branded-generics-assets-from-abbott-020315-4522715/ 2015-03-02T03:50:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-sobi-report-positive-top-line-results-from-phase-iii-kids-b-long-trial-of-alprolix-020315-4522738/ 2015-03-02T03:52:00+00:00 https://www.pharmaceutical-business-review.com/news/cel-sci-gets-clearance-to-conduct-phase-iii-trial-of-cancer-drug-multikine-in-21-countries-020315-4522771/ 2015-03-02T08:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-completes-20bn-three-part-asset-swap-deal-with-novartis-030315-4523425/ 2015-03-03T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/celgenes-lung-cancer-drug-abraxane-gets-approval-in-europe-030315-4523593/ 2015-03-03T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/aliz-pharma-begins-phase-ii-trial-of-azp-531-to-treat-prader-willi-syndrome-030315-4523673/ 2015-03-03T03:37:00+00:00 https://www.pharmaceutical-business-review.com/news/aquinox-completes-patient-enrollment-in-phase-ii-leadership-trial-of-aqx-1125-to-treat-bpsic-030315-4523698/ 2015-03-03T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-seeks-german-approval-to-begin-phase-iib-trial-of-leukemia-drug-candidate-bl-8040-030315-4523720/ 2015-03-03T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-introduces-thyroid-cancer-drug-lenvima-in-us-030315-4523773/ 2015-03-03T03:45:00+00:00 https://www.pharmaceutical-business-review.com/news/kite-pharma-expands-crada-with-nci-for-new-cancer-immunotherapy-products-030315-4523811/ 2015-03-03T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/indias-sun-pharma-agrees-to-buy-gsk-opiates-in-australia-040315-4524595/ 2015-03-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/blueprint-alexion-to-advance-development-of-kinase-drug-candidates-040315-4524817/ 2015-03-04T03:14:00+00:00 https://www.pharmaceutical-business-review.com/news/anabolic-enters-into-distribution-agreement-with-emerson-ecologics-040315-4524856/ 2015-03-04T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/cerulean-gog-to-conduct-phase-ib-trial-of-crlx101-combination-to-treat-ovarian-cancer-040315-4524786/ 2015-03-04T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-xydalba-gets-approval-in-europe-to-treat-absssi-040315-4524933/ 2015-03-04T03:30:00+00:00 https://www.pharmaceutical-business-review.com/news/islet-brighthaven-ventures-ink-license-deal-for-phase-ii-sglt2-inhibitor-remogliflozin-040315-4524996/ 2015-03-04T04:15:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-acquires-rights-to-actavis-lung-drugs-040315-4524623/ 2015-03-04T04:18:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-cancer-drug-opdivo-gets-fda-approval-to-treat-nsclc-050315-4525690/ 2015-03-05T00:09:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-merck-to-develop-new-combination-regimens-for-multiple-cancer-types-050315-4525931/ 2015-03-05T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-new-indication-of-pfizers-prevenar-13-050315-4526005/ 2015-03-05T03:34:00+00:00 https://www.pharmaceutical-business-review.com/news/bayers-bla-for-kovaltry-gets-fda-acceptance-to-treat-hemophilia-a-050315-4526041/ 2015-03-05T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-to-buy-cancer-drugmaker-pharmacyclics-for-21bn-050315-4525846/ 2015-03-05T04:02:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-enters-into-975m-deal-for-bavarian-nordics-prostvac-to-treat-prostate-cancer-050315-4525973/ 2015-03-05T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-gets-canadian-rights-to-sanofis-altace-and-altace-to-treat-hypertension-050315-4526111/ 2015-03-05T08:18:00+00:00 https://www.pharmaceutical-business-review.com/news/arrowhead-buys-novartis-rnai-research-and-development-portfolio-060315-4526430/ 2015-03-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hospira-recalls-a-lot-of-magnesium-sulfate-in-5-dextrose-injection-060315-4529254/ 2015-03-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/vanda-pharmaceuticals-declares-tradipitant-phase-ii-proof-of-concept-study-results-for-chronic-pruritus-060315-4526610/ 2015-03-06T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/axsomes-axs-02-drug-secures-us-fdas-fast-track-designation-060315-4526620/ 2015-03-06T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-buys-suppremol-in-200m-deal-060315-4526628/ 2015-03-06T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/oncology-venture-lantern-pharma-secure-icip-grant-for-irofulven-in-treating-metastatic-prostate-cancer-4526654/ 2015-03-06T02:49:00+00:00 https://www.pharmaceutical-business-review.com/news/tg-therapeutics-to-develop-checkpoints-antibodies-in-hematological-malignancies-060315-4526646/ 2015-03-06T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-astellas-cresemba-to-treat-zygomycosis-090315-4526971/ 2015-03-09T00:24:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-eliminate-up-to-110-employees-in-china-090315-4527091/ 2015-03-09T01:18:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/nih-led-partnership-launches-new-data-sharing-portal-for-alzheimers-drug-discovery-090315-4527191/ 2015-03-09T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/uks-nice-draft-guidance-recommends-apixaban-for-blood-clots-090315-4527290/ 2015-03-09T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/royal-philips-university-of-california-team-up-on-breast-cancer-screening-technology-090315-4527252/ 2015-03-09T03:42:00+00:00 https://www.pharmaceutical-business-review.com/news/sandoz-receives-fda-approval-for-zarxio-090315-4527432/ 2015-03-09T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-emergent-biosolutions-initiate-mor209es414-phase-i-trial-for-prostate-cancer-090315-4527757/ 2015-03-09T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/concordia-to-acquire-commercial-assets-of-covis-pharmaceuticals-for-12bn-100315-4528021/ 2015-03-10T00:40:00+00:00 https://www.pharmaceutical-business-review.com/news/korean-biotech-firm-g-treebnt-obtains-funding-to-develop-rgn-259gbt-201-in-us-100315-4528217/ 2015-03-10T03:08:00+00:00 https://www.pharmaceutical-business-review.com/news/glide-extends-subcontract-with-pfenex-for-solid-dose-formulation-of-rpa-based-anthrax-vaccine-100315-4528283/ 2015-03-10T03:11:00+00:00 https://www.pharmaceutical-business-review.com/news/recro-pharma-agrees-to-buy-assets-from-alkermes-for-170m-100315-4528232/ 2015-03-10T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/emd-serono-amends-deal-with-opexa-for-multiple-sclerosis-drug-tcelna-100315-4528349/ 2015-03-10T04:01:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-corbus-ind-to-begin-phase-ii-trial-of-resunab-to-treat-scleroderma-100315-4528410/ 2015-03-10T04:02:00+00:00 https://www.pharmaceutical-business-review.com/news/lexicon-completes-patient-enrollment-in-phase-iii-trial-of-telotristat-etiprate-100315-4528437/ 2015-03-10T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/medimmune-joslin-to-advance-metabolic-disease-research-110315-4529114/ 2015-03-11T00:10:00+00:00 https://www.pharmaceutical-business-review.com/news/ultra-zx-labs-recalls-ultra-zx-weight-loss-supplements-110315-4529586/ 2015-03-11T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/jjs-mcneil-ppc-pays-25m-over-manufacturing-adulterated-infants-childrens-otc-medicines-4529532/ 2015-03-11T04:18:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-introduces-generic-temovate-in-us-110315-4529679/ 2015-03-11T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/puma-begins-phase-ii-trial-of-breast-cancer-drug-neratinib-110315-4529710/ 2015-03-11T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/united-therapeutics-gets-fda-approval-for-unituxin-to-treat-pediatric-high-risk-neuroblastoma-110315-4529809/ 2015-03-11T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/inmed-university-of-debrecen-to-develop-new-phytocannabinoid-therapies-for-ocular-allergies-110315-4529833/ 2015-03-11T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-seeks-european-approval-for-eylea-to-treat-myopic-cnv-120315-4530310/ 2015-03-12T00:27:00+00:00 https://www.pharmaceutical-business-review.com/news/endo-confirms-bid-to-buy-salix-pharmaceuticals-for-112bn-120315-4530468/ 2015-03-12T02:43:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-requests-additional-data-for-lpaths-ind-for-lpathomab-120315-4530634/ 2015-03-12T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-transfers-license-agreement-for-hpv-vaccine-to-kaketsuken-120315-4530662/ 2015-03-12T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mercks-melanoma-drug-pembrolizumab-to-be-made-available-for-patients-under-eams-120315-4530751/ 2015-03-12T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/transgenomic-expands-license-deal-with-exiqon-for-lna-oligonucleotides-120315-4530696/ 2015-03-12T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/nice-approves-roches-blood-cancer-drug-gazyvaro-120315-4530601/ 2015-03-12T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-bms-resubmitted-nda-for-daclatasvir-to-treat-hcv-genotype-3-130315-4531386/ 2015-03-13T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-releases-top-line-results-from-phase-iv-trial-of-fibromyalgia-drug-lyrica-130215-4531325/ 2015-03-13T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/breckenridge-files-anda-with-paragraph-iv-certification-for-generic-version-of-boehringers-pradaxa-130315-4531590/ 2015-03-13T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/multicell-oxis-biotech-to-develop-three-new-antibody-drug-conjugates-130315-4531614/ 2015-03-13T02:54:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-iroko-nda-for-solumatrix-meloxicam-in-osteoarthritis-pain-130315-4531595/ 2015-03-13T02:56:00+00:00 https://www.pharmaceutical-business-review.com/news/afaxys-launches-first-otc-emergency-contraceptive-econtra-ez-130315-4531646/ 2015-03-13T03:01:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-sells-stake-in-aspen-for-850m-130315-4531945/ 2015-03-13T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-reports-positive-phase-iii-trial-results-of-bax-817-160315-4532253/ 2015-03-16T00:26:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-actavis-snda-for-saphris-to-treat-manic-or-mixed-episodes-of-bipolar-i-disorder-160315-4532521/ 2015-03-16T04:07:00+00:00 https://www.pharmaceutical-business-review.com/news/samsung-submits-maa-for-infliximab-biosimilar-candidate-to-ema-160315-4532556/ 2015-03-16T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-second-genome-to-discover-new-treatment-for-microbiome-mediated-diseases-160315-4532591/ 2015-03-16T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-and-regeneron-report-18-month-results-of-odyssey-long-term-trial-of-praluent-160315-4532765/ 2015-03-16T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-reports-positive-results-from-osler-1-and-osler-2-trials-of-repatha-160315-4532730/ 2015-03-16T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-releases-full-results-from-pegasus-timi-54-trial-of-brilinta-160315-4532815/ 2015-03-16T10:56:00+00:00 https://www.pharmaceutical-business-review.com/news/salix-accepts-valeants-revised-173-a-share-cash-deal-endo-withdraws-170315-4533424/ 2015-03-17T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/vaxil-bios-multiple-myeloma-drug-immucin-gets-orphan-drug-status-in-europe-170315-4533613/ 2015-03-17T03:03:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-actavis-viibryd-20mgday-dose-to-for-adults-with-mdd-170315-4533634/ 2015-03-17T03:12:00+00:00 https://www.pharmaceutical-business-review.com/news/tokai-qiagen-to-develop-ar-v7-companion-diagnostic-for-use-with-galeterone-170315-4533664/ 2015-03-17T03:20:00+00:00 https://www.pharmaceutical-business-review.com/news/axxess-gets-fda-approval-for-high-potency-omega-3-recovery-supplements-170315-4533711/ 2015-03-17T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/cannigistics-to-offer-clinical-trials-software-platform-for-canadian-medical-firm-170315-4533751/ 2015-03-17T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/emergent-completes-proof-of-concept-production-of-new-ebola-vaccine-170315-4533797/ 2015-03-17T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/novartiss-cancer-drug-jakavi-gets-approval-in-europe-to-treat-polycythemia-vera-180315-4534444/ 2015-03-18T00:09:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-completes-acquisition-of-allergan-for-705bn-180315-4534810/ 2015-03-18T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/lupin-agrees-to-buy-remaining-40-stake-in-south-africas-pharma-dynamics-180315-4534898/ 2015-03-18T03:39:00+00:00 https://www.pharmaceutical-business-review.com/news/celldex-roche-to-evaluate-varlilumab-and-mpdl3280a-combination-in-renal-cell-carcinoma-180315-4534939/ 2015-03-18T03:42:00+00:00 https://www.pharmaceutical-business-review.com/news/cloud-pharma-uf-department-of-medicine-to-accelerate-development-of-new-cancer-inhibitors-180315-4534957/ 2015-03-18T03:46:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-alcon-in-110m-lawsuit-over-gender-discrimination-180315-4534657/ 2015-03-18T04:06:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-johnson-johnson-invest-in-100m-new-alzheimers-rd-project-180315-4535040/ 2015-03-18T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-reports-positive-results-from-pt003-phase-iii-pinnacle-trials-in-copd-190315-4535585/ 2015-03-19T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/seltens-pah-treatment-tacrolimus-gets-fda-orphan-drug-status-190315-4535781/ 2015-03-19T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmalink-buys-synartros-product-candidate-to-treat-inflammation-associated-with-osteoarthritis-190315-4535665/ 2015-03-19T03:01:00+00:00 https://www.pharmaceutical-business-review.com/news/nantworks-sorrento-to-discover-and-develop-new-anti-cancer-immunotherapies-190315-4535810/ 2015-03-19T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/vertexs-kalydeco-gets-fda-aapproval-for-children-with-cystic-fibrosis-190315-4535745/ 2015-03-19T03:04:00+00:00 https://www.pharmaceutical-business-review.com/news/lexicon-ipsen-to-commercialize-telotristat-etiprate-in-canada-190315-4535871/ 2015-03-19T04:11:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-holding-buys-idd-biotechs-pre-clinical-stage-antibodies-and-related-patents-190315-4535905/ 2015-03-19T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-daiichi-to-jointly-commercialize-constipation-drug-movantik-in-us-200315-4536538/ 2015-03-20T00:24:00+00:00 https://www.pharmaceutical-business-review.com/news/medimmune-fapesp-to-identify-new-early-research-projects-in-brazil-200315-4536727/ 2015-03-20T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-hanmi-to-develop-btk-inhibitor-to-treat-autoimmune-diseases-200315-4536735/ 2015-03-20T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/immunocellular-pharmacell-partner-for-european-production-of-cancer-immunotherapy-ict-107-200315-4536767/ 2015-03-20T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-enters-into-license-deal-with-c2n-diagnostics-for-alzheimers-disease-therapy-200315-4536785/ 2015-03-20T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-pharmaceuticals-acquires-ichorcumab-developer-xo1-limited-200315-4536844/ 2015-03-20T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/prometic-completes-phase-ib-trial-of-pbi-4050-in-ckd-patients-200315-4536748/ 2015-03-20T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-reports-positive-results-from-phase-ii-psoriasis-trial-230315-4537372/ 2015-03-23T00:22:00+00:00 https://www.pharmaceutical-business-review.com/news/dilaforette-gets-fda-orphan-drug-status-for-sevuparin-to-treat-sickle-cell-disease-230315-4537683/ 2015-03-23T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-reports-positive-interim-phase-ib-results-of-aducanumab-to-treat-alzheimers-disease-230315-4537599/ 2015-03-23T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-seeks-japanese-approval-for-repatha-to-treat-high-cholesterol-230315-4537472/ 2015-03-23T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-partners-with-chinas-innovent-for-new-oncology-therapies-230315-4537732/ 2015-03-23T04:04:00+00:00 https://www.pharmaceutical-business-review.com/news/alzheon-releases-positive-phase-i-data-of-alz-801-to-treat-alzheimers-disease-230315-4537849/ 2015-03-23T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/akorn-expands-ophthalmic-portfolio-with-phenylephrine-hcl-ophthalmic-solution-launch-230315-4537878/ 2015-03-23T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-cold-spring-harbor-lab-to-develop-new-drugs-for-obesity-and-diabetes-240315-4538366/ 2015-03-24T00:14:00+00:00 https://www.pharmaceutical-business-review.com/news/mast-therapeutics-to-develop-vepoloxamer-to-treat-chronic-heart-failure-240315-4538702/ 2015-03-24T03:21:00+00:00